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ABSTRACT 
Type 2 diabetes is a disease characterised by a decrease in the sensitivity to 
insulin. Recently evidence has suggested an involvement of the 
microvasculature in the development of type 2 diabetes. Microvascular perfusion 
is increased by insulin and impairment of this response may contribute to muscle 
insulin resistance by limiting insulin and glucose delivery to skeletal muscle 
myocytes. This thesis focuses on the involvement of the microvascular perfusion 
in the development of insulin resistance. 
Two different models were used to assess the impact of the microvascular 
perfusion on the insulin-mediated glucose disposal. Firstly, 4 weeks of high-fat 
diet (HFD model) feeding to rats was used as a pre-diabetic model of insulin 
resistance. Secondly, partial blockage of skeletal muscle microvascular beds 
with 15 µm diameter latex microspheres (MS model) was used to assess the 
effect of decreased muscle microvascular perfusion on insulin sensitivity. 
In each model, insulin sensitivity was determined during hyperinsulinaemic 
isoglycaemic clamps in anaesthetized rats. Femoral arterial blood flow (FBF) 
and microvascular perfusion (assessed by the hindleg metabolism of infused 1-
methylxanthine) were measured. Hindleg glucose uptake was determined from 
arteriovenous difference and FBF and muscle glucose uptake from [14C]-2-
deoxyglucose uptake. 
Insulin-mediated increases in femoral blood flow and glucose uptake were 
blunted in the HFD rats compared to those on the normal diet, while insulin-
induced microvascular perfusion was completely abolished. To see whether 
contraction responses were intact on the HFD, the functional response to 
electrical stimulation in the HFD rats was explored. The contraction-mediated 
increase in microvascular perfusion and glucose uptake was unaffected by the 
HFD. 
In the MS model, microsphere occlusion of hindleg muscle microvasculature 
diminished microvascular perfusion as well as insulin-mediated glucose uptake, 
thus causing a vascular-derived acute state of insulin resistance. Next, the long-
term effect of microsphere occlusion was assessed. Surprisingly, insulin 
responses following chronic microsphere occlusion were restored by 2 weeks of 
xm 
recovery post-injection. This may be explained by a rapid angiogenic response 
in occluded muscle vasculature. 
Collectively, this thesis demonstrates two key findings that highlight the 
potential role of the microvasculature in the development of skeletal muscle 
insulin resistance: (i) that insulin- but not contraction-mediated microvascular 
responses are impaired in a pre-diabetic model of insulin resistance, and (ii) that 
acute physical reduction of microvascular flow impairs muscle insulin 
sensitivity. This furthers our understanding of the aetiology of type 2 diabetes 
and emphasizes the microvasculature as an interesting therapeutic target for the 
management of type 2 diabetes. 
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CHAPTER 1: INTRODUCTION 
1.1 INTRODUCTION 
In 2004-05, more than half (53 %) of the Australian population, or 7.4 million 
people were either overweight or obese (ABS 2008). Obesity poses a major risk 
to long-term health by increasing the risk of chronic illnesses such as diabetes. 
An estimated 5 % of the Australian population in 2008 has diagnosed type 2 
diabetes with an annual health cost estimated of one billion (ABS 2008). 
Globally, the World Health Organization estimated the prevalence of type 2 
diabetes at 160 million in 2000, and the prevalence is expected to double before 
2030 (WHO 2009). 
Type 2 diabetes is a chronic disease that occurs when the body cannot 
effectively use the insulin it produces, leading to a rise in blood glucose. Over 
time, type 2 diabetes lead to many complication including: heart disease and 
stroke, hypertension, atherosclerosis, nephropathy, neuropathy, and retinopathy 
(WHO 2009). Even though type 2 diabetes has been a subject of intensive 
research, the underlying mechanisms remain relatively poorly understood. 
Unravelling how insulin resistance progresses to diabetes would be invaluable as 
it may lead to the therapeutic strategies to prevent the development of this 
disease. In addition, determining the role of obesity, and how it influences the 
rate of this progression, is an important factor to consider. 
1.2 PHYSIOLOGICAL EFFECTS OF INSULIN 
The metabolic actions of insulin have been known since the 1920s, but in the last 
2 decades, the novel vascular actions of insulin have been uncovered. These 
include an increase in total blood flow and enhanced microvascular recruitment. 
This increase in blood flow and recruitment is responsible for approximately 50 
% of insulin-mediated glucose uptake in skeletal muscle (Youd 2000). 
Interestingly, in late stage type 2 diabetes, the vascular actions of insulin have 
been shown to be impaired (Wallis 2002, Clerk 2007). A decreased in the 
vascular actions of insulin will lead to decreased delivery of insulin and glucose 
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to the skeletal muscle and a decrease in insulin-mediated glucose uptake. This 
thesis explores the possibility that impaired microvascular recruitment may be a 
major initial defect leading to insulin resistance. 
Insulin mediates its mam metabolic action via the PI3K/Akt intracellular 
pathway (Figure 1 ). Upon reaching a target cells, insulin binds to its tyrosine 
kinase receptor, leading to activation of insulin receptor substrate (IRS) by 
phosphorylation on the tyrosine residue (White 1994). This creates a Src 
homology 2 (SH2)-binding domain on IRS, which the regulatory p85 subunit of 
PI3K will bind, in tum activating its catalytic pl 10 subunit (Folli 1992, Vincent 
2003). This results in phosphorylation of the 3'-0H position of the inositol ring 
of plasma membrane inositol phospholipids, generating increased levels of 
phophatidylinositol-3,4,5 triphosphate (PIP3). This molecule is specifically 
recognised by protein containing pleck-strin homology (PH) domains. The 3 ' -
phosphoinositide-dependent kinase 1 (PDK-1) possess such a domain (Mora 
2004), and upon its activation, will phosphorylate the Thr308 residue of Akt 
(Alessi 1996). Akt is a very important intracellular signalling intermediate 
known for its regulation of many downstream proteins (Gual 2005). 
In skeletal muscle, Akt activation leads to an increase in glucose uptake by 
recruiting the transmembrane glucose transporter GLUT-4 to the plasmatic 
membrane and the T-tubule (Kim 2006). This mechanism involves the activation 
of Akt substrate 160 (AS 160) (Bruss 2005). In the endothelial cell of the skeletal 
muscle vasculature, insulin leads to the Akt-mediated phosphorylation of eNOS 
on Ser1177 (Zeng 2000) and the production of nitric oxide (NO). This molecule is 
an important mediator of the endothelial dependent vasodilation (Moncada 
1987). Therefore, insulin can increase the vasodilation of vessels through an 
increased release of NO by the stimulation of endothelial cell (Scherrer 1994). It 
is interesting that both metabolic and vascular actions of insulin share similar 
intracellular signalling pathways. 
3 
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Figure 1: Insulin signalling. 
Intracellular insulin signalling of the Pl3KJAkt pathway. Activation of this 
pathway in the myocyte leads to the recruitment to the membrane of glucose 
transporter GLUT-4. Jn the endothelial cell this pathway results in NO 
production, a know vasodilatator. Adapted from (Muniyappa 2007) 
It should be mentioned that the binding of insulin to its receptor also activates a 
second intracellular pathway, the Ras/MAPK pathway. This pathway is 
responsible for effects of insulin on gene expression, cell growth and 
differentiation (Muniyappa 2007). Furthennore, the Ras/MAPK pathway has 
been shown to be intact in states of insulin resistance, while the PI3KJ Akt is 
defective (Jiang 1999, Cusi 2000). As insulin resistance is accompanied by 
compensatory hyperinsulinernia, this increases will led to the over activation of 
the Ras/MAPK pathway. As the MAPK pathway have been shown to be able to 
phosphorylate IRS-1 on serine residues (De Fea 1997), this can further impair 
the activation of the PI3K pathway (Dunaif 1995). 
4 
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1.3 AETIOLOGY OF THE DEVELOPMENT OF TYPE 2 
DIABETES 
Insulin, a peptide hormone synthetised in the pancreas by the P-cells of the islet 
of Langerhans, is secreted in response to increased blood glucose. Insulin is the 
main hypoglycaemic hormone and its action is diminished in type 2 diabetes. 
The type 2 diabetic state is defined as a loss of control of the blood glucose by 
the body. The aetiology of diabetes can split into three phase (Figure 2). First, 
the insulin resistant phase occurs when there is a failure of insulin to exert its 
normal effects. Physiological concentrations of insulin fail to suppress hepatic 
glucose output and to increase glucose disposal into muscle. Therefore, in order 
to achieve normal level of blood glucose, the pancreas needs to secrete 
abnormally high amounts of insulin. The second phase occurs when this high 
insulin secretion is no longer able to maintain the glycaemia within normal range 
(fasting value <130 mg/dl) (ADA 2009). It is at this point that insulin 
resistance/diabetes is usually diagnosed. The third phase occurs after chronic 
exposure (many years) to the diabetic phenotype. Over a long period, the 
pancreas is unable to sustain these high levels of secretion and P-cell failure 
occurs. Therefore, the production of insulin by the pancreas becomes insufficient 
to maintain normal blood glucose levels and uncontrolled hyperglycemia results. 
These three phases are illustrated in Figure 2. As the insulin resistant phase 
occurs very early in the pathogenesis of diabetes, understanding its evolution is 
crucial in the prevention of type 2 diabetes. 
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Figure 2: Aetiology of type 2 diabetes. 
Graphic representation of blood glucose and pancreatic function during the 
development of Type 2 diabetes over the years. The development of type 2 
diabetes can be separated into 3 phases. (1) The insulin resistant stage, often 
associated with obesity, is characterised by an increase in blood insulin. This is 
required as the body is less responsive to the actions of insulin. Early on, the 
increase in blood insulin is sufficient to maintain blood glucose in a no1mal 
range. (2) This is followed by the diabetic state, where the fasting blood glucose 
is higher than 130 mg/di. This occurs when the overproduction of insulin 
become insufficient to maintain blood glucose within physiological range. (3) 
The later phase happens when the pancreatic production of insulin falls and ~­
cell fa ilure occurs. This is a very late stage in the progression of the disease, and 
afflicted subject would require daily injection of exogenous insulin to maintain 
their blood glucose. 
IFG = impaired fasting glucose. 
(Adapted from International Diabetes Center (IDC), Minneapolis, Minnesota) 
Type 2 diabetes is a difficult disease to investigate as it appears to results from a 
combination of factors. The occurrence and severity of this disease in each 
patient depends on environmental factors such as their level of fitness , weight, 
and diet but also on genetic predisposition. Despite this, skeletal muscle insulin 
resistance, define by decrease insulin-mediated glucose uptake in the skeletal 
muscle, is a common feature of the disease and a major contributor to its 
development (Reaven 1988, Defronzo 1991 ). Insulin-mediated glucose uptake is 
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regulated at three points in skeletal muscle: Firstly, by the delivery of blood rich 
in insulin and glucose to the muscle, secondly by the trans-endothelium transport 
of insulin from the circulation to the interstitium, and thirdly by the intracellular 
signalling pathway leading to glucose uptake once insulin is bound to its 
receptor on the cell surface of the myocyte. This thesis focuses on the first point 
of control and discusses how impairment of the delivery of insulin and glucose 
to the skeletal muscle could be implicated in the early development of insulin 
resistance. Furthermore, it is important to discern between bulk delivery of blood 
and the effective delivery of glucose. Increase in total blood flow does not 
necessary correlate with increase delivery of insulin and glucose to the skeletal 
muscle (Rattigan 1997). The redistribution of blood flow within discrete region 
of the muscle is crucial to the proper disposal of glucose. This point will be 
explored in further details in section 1.5.2.1.1and1.5.2.2. 
1.4 SKELETAL MUSCLE INSULIN RESISTANCE 
The skeletal muscle is an extremely important organ for insulin-mediated 
glucose disposal, as it accounts for about 80 % of the insulin-mediated glucose 
uptake after a meal (Defronzo 1988). In addition, muscle insulin resistance is a 
precursor to the hyperglycemia observed in patients with glucose intolerance or 
type 2 diabetes (Reaven 1988, Defronzo 1991) underscoring the contribution of 
the skeletal muscle to the insulin resistant phenotype. Therefore, skeletal muscle 
is a prime target for the early defects in the development of insulin resistance, 
although the exact mechanism remained largely unknown. Different cellular 
mechanisms have been proposed to explain the skeletal muscle insulin 
resistance, with the major theories outlined below. 
1.4.1 Fatty Acid Excess 
Increases in circulating free fatty acid (FF A) are observed in type 2 diabetes 
patients (Reaven 1988) and have therefore been hypothesised to be responsible 
for the insulin resistance (Reaven 1988). The elevated FF A could be a result of 
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an increased dietary intake, but could also result from a resistance to insulin at 
the adipocyte leading to an increased activity of the hormone-sensitive lipase 
resulting in breakdown of triglycerides and release of FF A into the circulation 
(Roden 1996). 
Two mechanisms have been proposed by which FF A may induce skeletal 
muscle insulin resistance. The first is that the decrease in glucose uptake could 
result from an interaction between lipid and glucose metabolism known as the 
fatty acid cycle or Randle cycle (Randle 1965). High circulating FF A levels 
leads to an increased oxidation of fatty acid and increased intra-mitochondrial 
content of acetyl-CoA. As a result, there is an increase in reduced/oxidized 
nicotinamide adenine dinucleotide (NADH/NAD+) ratio, which in tum inhibits 
the pyruvate dehydrogenase (PDH) activity. The increase fatty acid oxidation 
will also lead to an accumulation of cytosolic citrate that will in tum inhibits 
PFK-1 (Garland 1963). Inhibition of PDH and PFK-1 leads to an increase 
glucose-6-phosphate levels that will inhibit hexokinase and then lead to decrease 
glucose uptake. However, the importance of this mechanism was called into 
question when it was revealed that reduction in carbohydrate oxidation was 
responsible for only one-third of the fatty acid-dependent decrease in glucose 
uptake (Boden 1994). 
The second mechanism by which FF A could decrease insulin-mediated glucose 
uptake is by a direct action on the insulin signalling (Shulman 2000). Increased 
circulating FF A will increase intracellular concentration of fatty acid 
metabolites, fatty acyl Co-A, ceramides and diacylglycerol (DAG) (Shulman 
2000, Machann 2004, Summers 2006). Accumulation of these intracellular fatty 
acid metabolites have been shown to impair the PI3K/ Akt insulin signalling 
cascade by activating PKC (0, ~II, and C>) and subsequent serine phosphorylation 
of IRS-1 (Griffin 1999, Itani 2002, Yu 2002, Guo 2007). IRS-1 is central in the 
insulin PI3K/Akt pathway (see Figure 1) and serine phosphorylation prevents 
the downstream transmission of the insulin activation (Gual 2005). 
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Infusion of intralipids and heparin has been used to study the effect of increased 
circulating FF A on insulin sensitivity. This procedure has been shown to cause 
insulin resistance in both rodents (Kraegen 2008) and human (Ferrannini 1983, 
Bonadonna 1989, Boden 1994, Dresner 1999). Intralipid infusion prevented up 
to 50 % of the normal insulin-stimulated glucose uptake during a 
hyperinsulinaemic clamp and after glucose ingestion and was associated with 
impairment of IRS-1 activation (Dresner 1999). 
The potential importance of FF A in the early development of insulin resistance 
is further supported by temporal studies of the obese Zucker rat (Liu 2002). Six-
week-old obese Zucker rats, presenting only mild insulin resistance, have a 2-
fold increase in the peripheral and portal levels of FF A when compared to their 
lean counterparts. This demonstrates that the increase in FF A precedes the 
appearance of hyperglycaemia and insulin resistance that is not apparent until 
~ 15 weeks of age in this model. These studies indicate that an increase in FF A 
may well be implicated in the early development of insulin resistance. 
1.4.2 Tumor Necrosis Factor-a 
Obesity is now known to be a chronic low inflammatory state (Hotamisligil 
2006, Lee 2009), and this inflammatory state may be involved in the 
development of insulin resistance. Tum or necrosis factor-a (TNF-a ), a 
proinflammatory cytokine, is produced and secreted from the adipose tissue and 
plays a major role in mediating immune responses (Wellen 2005). Furthermore, 
TNF-a has been implicated as a critical mediator of insulin resistance, 
particularly in relation to obesity (Hotamisligil 1993, Hofinann 1994, 
Hotamisligil 1996). Expression of TNF-a is strongly correlated with reduced 
insulin-stimulated glucose disposal (Saghizadeh 1996, Kern 2001) and genetic 
ablation of TNF-a restores skeletal muscle insulin sensitivity in obese rodents 
(Uysal 1997). TNF-a has been shown to impair insulin signalling by 
phosphorylation of IRS-1 on Ser312, Ser 636, and Ser1101 (Gual 2005, Schenk 
2008). A number of different protein kinases have been implicated in the 
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inhibition ofIRS signalling by TNF-a and include PKC (Yu 2002), IKB-a kinase 
(Gao 2002) and c-jun NH2-tenninal kinase (Aguirre 2000). All these kinases 
were initially indentified as critical mediators of inflammatory signalling (Gual 
2005). Given its association with obesity, TNF-a may, with FFA, also be an 
important mediator in the early development of insulin resistance. 
Infusion of TNF-a in viva has been shown to inhibit insulin-mediated glucose 
uptake in rats. Acute infusion of TNF-a in the anaesthetised rat induced mild 
systemic insulin resistance, as seen by the 21 % decrease in glucose infusion rate 
during euglycaemic hyperinsulinaemic clamp (Youd 2000), and a ~50 % 
decrease in insulin-mediated skeletal muscle glucose uptake. Similar effects 
were observed in humans, where TNF-a infusion decrease the glucose infusion 
rate during hyperinsulinaemic clamp and prevented activation of the IRS and 
AS 160 by insulin in the skeletal muscle (Plomgaard 2005). While in viva 
experiments with systemic infusion of TNF-a leads to muscle insulin resistance, 
incubated skeletal muscle have failed to show any effect of TNF-a on insulin 
signalling and glucose uptake (Fumsinn 1997, Nolte 1998). Explanation for this 
may reside in the experimental procedure used. Indeed, incubated muscle does 
not involve the vasculature for nutrient delivery. However, in vivo, vascular 
delivery has been shown to be important and compromised by TNF-a (Youd 
2000, Zhang 2003). In these studies, TNF-a was shown to prevent the insulin-
mediated microvascular recruitment, leading to impaired glucose uptake. 
Therefore, the effect of TNF-a on impaired insulin sensitivity may be due to its 
vascular actions rather than actions within the myocyte. The physiological 
importance of the vascular actions will be further discussed in section 1.5. 
1.4.3 Endothelial Dysfunction 
As stated~ previously in section 1.2, NO is a potent vasodilator produced by 
endothelial cells. Endothelial dysfunction is defined as impairment of the NO 
synthesis and/or increase degradation of NO in response to stimuli, such as 
acetylcholine, and insulin. (Li 2000). Macro- and micro-vascular actions of 
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insulin have been shown to rely on the production of NO (Baron 1994, Scherrer 
1994, Steinberg 1994, Vincent 2003, Potenza 2009), and impairment in this NO 
production has been shown to be present in insulin resistant muscle (Williams 
1996, Young 1998, Vincent 2003, Muniyappa 2007, Kearney 2008). 
Oxidative stress is thought to be partially responsible for endothelial dysfunction 
in type 2 diabetes, and can be explained by an overproduction of superoxide 
induced by chronic hyperglycaemia (Brownlee 1981). Increased presence of 
superoxide molecule has been shown to affect caveolae formation, endothelial 
NOS expression, and endothelial NOS-caveolin interactions (Peterson 1999), all 
leading to decrease NO bioavailability. Moreover, elevated glucose has also 
been shown to impair endothelial cell function via IKK downregulation of the 
IRS/PI3K pathway (Kim 2005). However, available data tends to favour the 
view that endothelial dysfunction precedes the development of type 2 diabetes 
(Anastasiou 1998, Lesniewski 2008) and even the skeletal muscle insulin 
resistance (Jansson 2007, Seme 2007). Therefore, it is unlikely that oxidative 
stress due to chronic hyperglycemia is responsible for endothelial dysfunction in 
the initial stage of insulin resistance. 
Interestingly, both TNF-a and FF A have been shown to impair the insulin-
mediated production of NO. In healthy humans, infusion of either TNF-a or FFA 
lead to impairment of the insulin-mediated increase in total blood flow 
(Steinberg 2000, Rask-Madsen 2003). In both cases, a decrease in insulin-
mediated NO production was identified as the cause. Furthermore, similarly to 
hyperglycaemia, increased exposure to FF A can activate IKK, which in tum will 
inactivate elements of the insulin-signalling pathway, resulting in a further 
decrease in endothelial NO production (Kim 2005). This association with 
endothelial dysfunction supports the notion that TNF-a and FFA are early 
factors in the development of insulin resistance. 
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1.4.4 Endoplasmic Reticulum Stress 
In the last 5 years, endoplasmic reticulum (ER) stress has been proposed as a 
molecular mechanism responsible for insulin resistance (Ozcan 2004, Eizirik 
2008). ER stress occurs when the influx of misfolded or unfolded peptides 
exceeds the ER processing capacity (Boden 2009). ER stress triggers the 
unfolded protein response (UPR) that will either slow the protein synthesis, 
increase production of chaperone to properly fold the protein, or increases 
degradation of the unfolded proteins (Schroder 2005). Activation of the UPR has 
been shown to activate several serine/threonine kinases, including IKK and JNK, 
which can induce insulin resistance via serine phosphorylation of IRS-1 (Zhang 
2008). Thus, the ER may be a proximal site that senses nutritional excess and 
translates it into metabolic responses. 
1.4.5 Leptin and Adiponectin Resistance 
Leptin and adiponectin are two adipokines that have recently stimulated much 
interest and may well be involved in the development insulin resistance. Leptin 
influences body weight homeostasis through effects on food intake and energy 
expenditure (Sierra-Honigmann 1998) while adiponectin is a known to be a 
insulin-sensitizing hormone (Lihn 2005) and to promote eNOS activity and the 
bioavailability of NO (Chen 2003, Tan 2004, Li 2007). Both adipokines have 
been shown to activate 5' AMP-activated protein kinase (AMPK) in the skeletal 
muscle and, as such, increase the rate of fatty acid oxidation and decrease 
muscle lipid content, which may in part be the underlying mechanism to their 
insulin sensitizing effect (Minokoshi 2002, Hardie 2003, Hattori 2008). 
Resistance to leptin and adiponectin results in the accumulation of intramuscular 
lipids, such as DAG and ceramides, which, as discussed above, may contribute 
to the development of insulin resistance (Dyck 2006). Resistance to adiponectin 
has been shown to precede the accumulation of skeletal muscle lipids and insulin 
resistance in high-fat-fed rats (Mullen 2009). Furthermore, it is interesting to 
note that TNF-a decreases the expression of adiponectin (Bruun 2003). 
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The difficulty to indentify only one culprit for the development of insulin 
resistance illustrates the complexity of this disease. Insulin resistance has such a 
complex pathophysiology that one single causative molecular culprit is unlikely 
to exist. While myocyte insulin resistance in fully establish type 2 diabetes is 
without question, the mechanism(s) leading to this is far from resolved. A novel 
new possibility is that the loss of myocyte insulin signalling may be a secondary 
response after a primary loss of vascular function. The evidence related to the 
different vascular actions of insulin, which supports such a proposition is 
discussed below. 
1.5 VASCULAR ACTIONS OF INSULIN 
1.5.1 Macrovascular Effect of Insulin 
The first observation of a vascular effect of insulin was made in 1939 by 
Abramson and colleagues (Abramson 1939). In this study, it was found that a 
bolus dose of 40-280U of insulin led to increased blood flow to the leg, forearm 
and hand of patients with schizophrenia. They found that insulin increased blood 
flow up to eight times, but since the experimental procedure did not include a 
compensatory glucose infusion, the vasodilatation attributed to insulin may also 
have been due to an increase in adrenaline levels resulting from the fall in blood 
glucose. However, in the early 1990s, Baron and colleagues demonstrated that 
increases in total blood flow was a novel action of insulin (Laakso 1990). The 
hyperinsulinaemic euglycaemic clamp (the gold standard to evaluate the insulin 
sensitivity) was used to eliminate the possible effects of counterregulatory 
hormones. Their studies were designed to assess the dose-dependent effects of 
insulin on glucose uptake and leg blood flow. They observed that leg blood flow 
increased in an insulin dose-dependent fashion along with whole body and 
muscle glucose uptake. The insulin-mediated flow response in lean men, (first 
increase in total blood flow at 300 pmol/l of serum insulin) was positively 
correlated with muscle glucose clearance. These findings were also confirmed 
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by others using various techniques to assess total blood flow in both human 
(Anderson 1991, Baron 1993, Utriainen 1995, Tack 1996, Ueda 1998) and 
animals (Liang 1982, Rattigan 1997, Vincent 2002, Zhang 2004). 
However, there was considerable variation between reported studies in the 
magnitude of the blood flow response to insulin, and some groups failed to 
observe any changes in flow with insulin (Jackson 1986, Yki-Jarvinen 1987, 
Ebeling 1993, Sakai 1993). This led to considerable controversy as to whether 
insulin action on total blood flow was physiologically relevant (Yki-Jarvinen 
1998, Steinberg 1999). While different measuring techniques have shown an 
insulin-mediated action on the total blood flow, the debate is centred on the 
experimental design. Many of the studies describing insulin-mediated increase in 
total blood flow used supra-physiologic or pharmacological dose of insulin 
(Baron 1993, Raitakari 1996, Bonadonna 1998), while studies showing small 
effects use more physiologically relevant doses of insulin that required several 
hours of insulin infusion before a change in blood flow was seen. (Laakso 1990, 
Anderson 1991, Vollenweider 1993). Moreover, an increase in FBF is not 
always associated with an increase in myocyte glucose uptake (Scherrer 1994, 
Nuutila 1996, Rattigan 1999). 
This led Baron and colleagues (Baron 1994) to postulate that, although not 
measured in their studies, the distribution of blood flow within the muscle 
microvasculature may be a more crucial factor in insulin sensitivity. This 
important microvascular action of insulin was confirmed by direct measures in 
subsequent studies by others. (Rattigan 1997, Coggins 2001, Seme 2001, 
Vincent 2002, de Jongh 2004, Vincent 2004, Zhang 2004). 
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1.5.2 Microvascular Effect of Insulin 
1.5.2.1 Structure of the Skeletal Muscle Microcirculatio11 
Figure 3 depicts the general circulation found within the skeletal muscle. The 
muscle vascular tree is comprised of three different types of vessels: arteries, 
capillaries and veins. The blood circulatory system within muscle starts with the 
feeding arteries, which are generally classified as first-order arteriole (Sweeney 
1989). In the subsequent branches, assigned higher order numbers, a reduction in 
arteriole diameters is observed until the capillaries are reached (Murrant 2000). 
As the diameter decreases, the smooth muscle cell content of the arterial vessel 
also decreases. Arterioles of 1 st to 3rd order(> 50 µm diameter) are thought to 
control the resistance and, as such, the total blood flow though the skeletal 
muscle (Segal 1986, Murrant 2000). The smaller arterioles of the 3rd through 5th 
order (10-40 µm diameter) are thought to control the capillary blood flow 
distribution and capillary recruitment (Honig 1982, Clerk 2004). Capillaries, 
which arise from a 5th order arterioles, are grouped together to fmm a capillary 
module made of ~15 capillaries. This module runs along the muscle fibre, with 
three to four capillaries generally surrounding each fibre. Each capillary is 
composed of a single layer of endothelial cells, which allows efficient exchange 
of gas and other molecules between the blood and the myocytes. Resistance in 
the microvasculature can also be regulated by capillary recruitment itself and is 
of particularly importance during hyperaemia (Jayaweera 1999). The capillaries 
module terminates at post-capillaries venules. As the venules combine, an 
increase in diameter size and amount of smooth muscle cells surrounding the 
endothelial lined lumen occurs. 
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Arteries Capillaries Veins 
Figure 3: Microvascular tree. 
The microvasculature is comprised of three different types of vessels: arteries, 
capillaries and veins. The skeletal muscle vascular system starts with the 
arteries, which are responsible for delivering the blood rich in nutrients and 
oxygen within the muscle. As arteries go deeper into the organ, the diameter and 
the smooth muscle cell content diminish. At the capillary level , only a single 
layer of endothelial cell exists. Capillaries allow efficient exchange of gas and 
other molecules between the blood and the myocytes. Venous vessels connected 
to the capillary beds groups together as they make their way out of the muscle. 
As such, their diameter and smooth muscle cell content increases. 
(Adapted from (Boron 2003)) 
The term microvasculature generally refers to vessels < 150 µm in diameter 
(Levy 2001 ). It therefore includes the capillaries and the smaller arterioles and 
venules. The primary function of the microcirculation is to optimise the delivery 
of nutrients and removals of waste products (Murrant 2000). As such, the 
perfusion of a tissue can be modulated by contraction of the smooth muscle cells 
of the terminal arterioles (5th order arterioles), therefore affecting the access of 
blood to this portion of the capillary module. 
The circulatory system in muscle however has a further level of complexity that 
involves two circuits in parallel. Early evidence for two circulatory systems in 
the muscle comes from a study of Pappenheimer in 1940s (Pappenheimer 1941 ). 
Clark and colleagues have since shown that distributions of blood toward one or 
the other of these two separate flow routes (nutritive and non-nutritive) result in 
very different metabolic effects (Clark 1995) 
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1. 5. 2.1.1 Non-Nutritive and Nutritive Routes 
The muscle microcirculation (Figure 4) is comprised of two distinct pathways: 
the non-nutritive and the nutritive route. Blood flow distribution between those 
two routes is under the control of vasoactive substances and the sympathetic 
nervous system (Clark 1995). Even though these two routes are contiguous and 
parallel inside the muscle, their functions are very different. 
Central 
Vein 
Muscle Connective 
tissue 
Figure 4: Schematic representation of the muscle vascular system. 
Transverse arteriole supplies both capilla1ies of the nutritive route (irrigating the 
myocytes) and the non-nutritive route (in close association with the connective 
tissue of the skeletal muscle). 
(Adapted from (Borgstrom 1988)) 
The nutritive route contains vessels that are considered to have extensive contact 
with the myocyte (Clark 1995). This network is composed of extremely tortuous 
capillaries that are evenly distributed inside the muscle, wrapping around the 
muscle fibre to allow efficient exchange. By providing a large surface area for 
optimal exchange within the muscle cells, the nutritive route allows exchange 
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between the blood and the muscle fibre. On the other hand, the non-nutritive 
route is more closely associated with the connective tissue of the perimysium 
and epimycium of the skeletal muscle, such as tendons (Newman 1997) and 
adipose tissue (Clerk 2000). Vessels composing this route are shorter, and 
possibly of slightly greater diameter (Vincent 2001) therefore giving this route a 
high capacitance with a low resistance. As this route irrigates cells with low 
metabolic activity, it is scarcely implicated in nutrient exchange. Several studies 
using different techniques have suggested that at rest non-nutritive flow is 
predominant (Clark 2000). Under insulin stimulation or exercise, there is a 
greater percentage of the nutritive capillaries perfused with the potential for 
increased delivery of nutrients, oxygen and hormone to the myocytes (Clark 
2000, Clark 2006). This increased is called microvascular recruitment. 
1.5.2.2 Microvascular Recruitment 
The term microvascular recruitment is used to describe an increase in capillary 
surface area within the skeletal muscle, which leads to increased delivery of 
glucose and insulin to the myocytes. Insulin-mediated microvascular recruitment 
is a result of the vasodilatory action of insulin, largely NO-dependent (Scherrer 
1994, Steinberg 1994, Vincent 2003), on the terminal arterioles controlling the 
access of blood and nutrients to the nutritive flow route. Changes in 
microvascular recruitment are independent of total blood flow and 
measurements of microvascular recruitment have been successfully assessed by 
many different techniques (Clark 2008), including 1-methylxanthine (1-MX) 
metabolism and contrast-enhanced ultrasound (CEU). These techniques have 
been pivotal in assessing the effect of insulin action on microvascular 
recruitment. 
1.5.2.2.1 1-Methylxanthine Metabolism 
The Hobart Muscle Research Group has demonstrated that insulin can increase 
microvascular recruitment (Rattigan 1997). The 1-MX technique is a 
biochemical assay for the measurement of capillary surface area due to increase 
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microvascular recruitment. Xanthine oxidase (XO) is an enzyme present at the 
luminal surface of capillaries and is practically absent from the bigger vessels 
(Jarasch 1986, Parks 1986). Perfused capillary surface area can be assessed by 
infusing 1-MX, a specific substrate of XO, into the blood stream. Increases in 
the capillary surface area will results in increase conversion of 1-MX to 1-
methyluric (1-MU), which is independent of the total blood flow to the muscle 
(Rattigan 1997). Using the Fick principal (Zierler 1961), the amount of 
microvascular recruitment is determined by multiplying the arterio-venous 
difference by the arterial blood flow rate. 1-MX is an ideal substrate for 
measurement of microvascular recruitment as it is not vasoactive (Rattigan 
1997) and does not affect metabolism (Rattigan 1997). Moreover, XO activity in 
the skeletal muscle does not change during acute treatment (Rattig€1ll 1997, 
Rattigan 1997). Therefore, the 1-MX technique can be used to measure 
microvascular recruitment without adverse effects due to the 1-MX infusion. 
The first direct evidence of insulin-mediated capillary recruitment was made by 
Rattigan and colleagues (Rattigan 1997), where they demonstrated that a 10 
mU/min/kg insulin infusion was able to increase the 1-MX metabolism, and as 
such the microvascular recruitment. The dose of insulin used (10 mU/min/kg) in 
this study increased the total FBF. To ensure that the increase in 1-MX 
metabolism was not due to a macrovascular effect of insulin (i.e. total flow), the 
effects of epinephrine treatment was also determined. Epinephrine infusion was 
adjusted to produce an increase in total blood flow similar to insulin and it was 
found that the epinephrine-mediated increase in FBF was not associated with a 
rise in capillary perfusion (no change in 1-MX metabolism). Thus, it was 
concluded that insulin possesses a specific action on the microvascular 
recruitment that lead to increased delivery of blood to muscle. The physiology of 
the microvascular recruitment process was further assessed by Zhang and 
colleagues (Zhang 2004) where they found a dose-dependent effect of insulin 
infusion on capillary recruitment, total blood flow and muscle glucose uptake in 
the anaesthetised rat. It was noted that a low, physiological increase in insulin 
( ~600 pmol/l) elicits an increase in capillary recruitment and glucose uptake, but 
not in total blood flow. This supported previous results indicating that glucose 
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uptake correlates well with microvascular recruitment but not with total blood 
flow (Rattigan 1999) demonstrating the physiological importance of the 
microvascufar recruitment in the glucose disposal. 
There are several limitations with the 1-MX technique. This technique requires 
an infusion protocol that leads to a constant concentration of 1-MX in the artery 
and requires a accurate measure of total blood flow to determine overall 
metabolism. Due to the volume of blood required for analysis it can only be used 
as an endpoint measurement m experimental animals. Furthermore, 
microvascular recruitment cannot be assessed in humans using the 1-MX 
technique, as the levels xanthine oxidase expression in human is far less than in 
rat (Rattigan 2005). Therefore, to circumvent these issues, a new technique to 
measured microvascular recruitment using contrast-enhanced ultrasound was 
developed. 
1.5.2.2.2 Contrast-Enhanced Ultrasound Studies 
Visualisation of the microvascular volume by contrast-enhanced ultrasound 
(CEU) is based on a technique initially develop for imaging the heart (Wei 
1998). This technique involved a systemic infusion of phospholipids or albumin 
gas-filled microbubbles to provide contrast for the ultrasound detection. 
Microbubbles are imaged and destroyed using pulses of high mechanical index 
ultrasound from a transducer probe positioned over the tissue of interest (i.e. 
muscle of the hindleg). The intensity of the signal received from bursting the 
microbubbles is proportional to their concentration and is recorded as acoustic 
intensity (AI). By triggering the ultrasound pulses at different time intervals, the 
microbubbles can replenish the perfused vascular system between each pulse of 
ultrasound. At short ultrasound pulsing intervals (0-1 s) only the large rapidly 
filling vessels will be refilled while longer pulsing intervals (20-25 s) all vessels 
(arteries, arterioles, capillaries, venules and veins) that are carrying the blood 
flow will be replenished with microbubbles. Subtraction of the shorter time 
interval enables the measurement of the microvascular blood volume (Coggins 
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2001). The rate at which the capillary vessels fill may also be assessed and a 
measure of microvascular blood flow may be determined by multiplying the 
microvascular blood volume and microvascular fill rate. 
Insulin-mediated increases in microvascular recruitment have been observed 
with the CEU technique (Coggins 2001, Vincent 2002, Vincent 2003, Zhang 
2004). Direct comparison between 1-MX and CEU measurement during an 
hyperinsulinaemic clamp was made by Zhang and colleagues (Zhang 2004) as 
well as Dawson and colleagues (Dawson 2002). They were able to show that 
during the euglycaemic hyperinsulinaemic clamp using physiological doses of 
insulin (1.5, 3, and 10 mU/min/kg), similar proportional increases in 
microvascular recruitment were measured using both techniques. Furthermore, 
the microvascular recruitment required less insulin than enhancement of total 
blood flow. The data supports the notion that microvascular recruitment and 
total blood flow are controlled separately. 
Another advantage of this technique is that CEU allows continuous measures of 
microvascular recruitment as opposed to the 1-MX method that can only be used 
to obtain endpoint measurement. CEU enables the time course of the 
microvascular recruitment and recruitment to be assessed in response to various 
stimuli. Increased microvascular recruitment was shown to be closely related to 
the rise in plasma insulin (Vincent 2006), and the insulin-mediated increase in 
capillary recruitment preceded insulin activation of the intracellular signalling 
pathway in the myocyte (Vincent 2004). Indeed, increases in muscle 
microvascular recruitment was noted after only 7 min of insulin infusion, while 
the increases in Akt phosphorylation and glucose uptake occur only after 30 min 
of infusion. This suggests that muscle metabolism is not fully responsible for the 
increase in perfusion during insulin stimulation. Furthermore, low, physiological 
3 mU/min/kg insulin infusion was shown to elicit an increase in capillary 
recruitment and this effect precedes the increases in total blood flow by as much 
as 60-90 min (Vincent 2002). This was confirmed in human studies with a 1 
mU/min/kg insulin infusion increasing microvascular recruitment by 20 min 
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prior to increases in forearm blood flow which occurred at 100 min (Eggleston 
2007). These experiments imply that blood flow has been redistributed from 
perfused vessels into previously unperfused capillaries. 
1.5.2.3 Microvascular Recruitment in Insulin Resistant State 
Microvascular recruitment has been assessed in different rat models of type 2 
diabetes. The obese Zucker rat, a genetic model of type 2 diabetes, has no 
insulin-mediated increase in microvascular recruitment and a blunting of the 
five-fold increase in insulin-mediated glucose uptake usually seen in their lean 
littermate (Wallis 2002). These observations are also true in the more severe 
model of type 2 diabetes, the Zucker Diabetic Fatty (ZDF) rat (Clerk 2007). 
During a euglycemic hyperinsulinaemic clamp, ZDF rats have a complete 
impairment of the insulin-mediated microvascular recruitment accompanied by a 
60-70 % decrease in glucose utilisation. Interestingly, treatment with 
angiogensin-converting enzyme (ACE) inhibitor Quinapril reversed the 
impairment microvascular recruitment and partially restored the glucose 
utilisation. Considering this data, impairment of the microvascular recruitment is 
present in type 2 diabetes and may, along with myocyte insulin-resistance, be 
responsible for the decrease in insulin-mediated muscle glucose uptake 
Impairment of the microvascular recruitment has also been observed in obese 
humans. In a study by Clerk and colleagues, microvascular recruitment of the 
forearm during a physiological insulin (1 mU/min/kg) clamp was assessed in 
both lean and obese patients (Clerk 2006). In lean subjects a 34 % increase in 
microvascular volume was observed, while there was no insulin-mediated 
change in the obese subjects. This microvascular dysfunction may affect the 
insulin-mediated glucose disposal by limiting the delivery of insulin and glucose 
to the skeletal muscle, thereby contributing to insulin resistance (Seme 1999, 
Seme 2001). These results are consistent with the data obtained in the skin 
capillaries of obese subject where impaired skin capillary recruitment, as well as 
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a decrease sensitivity of resistance vessels to insulin-induced endothelium 
dependent vasodilation, was observed during hyperinsulinemia (de Jongh 2004). 
Evidence that the loss of insulin-mediated microvascular recruitment may 
precede and therefore be responsible for the skeletal muscle insulin resistance is 
also supported by results that show the effects of acute blockade of insulin-
mediated microvascular recruitment. Infusion of intralipids (Clerk 2002), Tumor 
Necrosis Factor-a (TNF-a) (Youd 2000), a-methylserotonin (Rattigan 1999) and 
L-NAME (Vincent 2003) have all been shown to acutely block insulin-mediated 
microvascular recruitment. All of these infusions resulted in an approximate 50 
% decrease of insulin-mediated skeletal muscle glucose uptake. Therefore, these 
data suggest that an impairment of insulin-mediated microvascular recruitment 
could very well be an initial stage of insulin resistance. It is noteworthy that both 
TNF-a and a-methylserotonin fail to affect the insulin-mediated glucose uptake 
in in vitro incubated muscle preparations (Nolte 1998, Rattigan 1999), 
suggesting that their effects are exclusively vascular. 
1.5.2.4 Vasomotion 
Vasomotion is defined as an oscillation of the vascular tone that is generated 
from the vascular wall itself (Nilsson 2003), which ensure distribution of blood 
within the different regions of the muscle. It is known that during rest, at any 
given time, about only a third of the muscle is actually perfused (Honig 1982). 
Therefore, vasomotion ensured that muscle is perfused sufficiently to sustain the 
prevailing metabolic demand and prevent hypoxia by periodically redistributing 
blood from one region of the muscle to another (Rucker 2000). Using 
mathematical analysis it was shown that vascular oscillation is comprised of five 
frequency components: heartbeat, respiratory, myogenic, neuronal and 
endothelial (Stefanovska 1999). Heartbeat, respiration and neuronal input 
oscillations are a result of separate and distal effects, and as such are not 
implicated in the "regional" vasomotion (or flowmotion). Flowmotion is a 
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consequence of the myogenic and endothelial inputs and may be affected locally 
by insulin. 
Recently, it was reported that insulin influences vasomotion in the skeletal 
muscle (Newman 2009). Using Laser Doppler Flowmetry (LDF) to assess 
muscle vasomotion, insulin was shown to increase the total LDF signal, as well 
as the myogenic frequency component. When the same measurements were 
made in an acute model of insulin resistance (infused a-methylserotonin), effects 
of insulin on both ~otal and myogenic frequency signals were blunted. This data 
gives support to the theory that insulin is able to act on the smooth muscle cell 
(responsible for the myogenic frequency) of the terminal arterial regulating the 
microvascular recruitment. Vascular dysfunction in insulin resistance may 
involve a specific loss of insulin to stimulate the vascular smooth muscle 
contribution to vasomotion/flowmotion in skeletal muscle. 
1.5.2.5 Other Possible Impairments of the Microvasculature in Type 2 
Diabetes 
Others defects of the skeletal microvasculature could also be implicated in type 
2 diabetes. These included a diminution in the number of capillaries and changes 
in the permeability of capillaries present inside the skeletal muscle. These two 
defects further emphasise the importance of the microvasculature in the type 2 
diabetes. 
1.5.2.5.1 Microvascular Rarefaction 
A decrease in the actual number of vessels of the microcirculation is termed 
microvascular rarefaction. As is the case with impaired microvascular 
recruitment, microvascular rarefaction results in increase diffusion distance, 
therefore leading to decreased delivery of the nutrients and hormones to 
myocytes. While microvascular rarefaction has been observed in hypertension 
(Levy 2001, Seme 2001), it may also be present in the later stage of type 2 
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diabetes. Indeed, microvascular rarefaction was observed in the obese Zucker rat 
(Frisbee 2005) where there was a decrease in the microvessel density in 
gastrocnemius muscle of 15-17 weeks old Zucker rats. This rarefaction was only 
present when type 2 diabetes was apparent. In 6-7 weeks old Zucker rats where 
only insulin resistance was present, the microvascular density was unchanged. 
This is consistent with other studies where the capillary density is unchanged in 
the early stage of insulin resistance (Zou 2003, Fueger 2007). The relevance of 
the rarefaction hypothesis is also undermined by the fact that a minority of 
capillaries are functionally open at baseline (Honig 1982, Klitzman 1982), 
therefore mild rarefaction would not have much of an effect. Furthermore, Clerk 
and colleagues (Clerk 2007) did not detect significant rarefaction in a rat model 
of insulin resistance. Therefore, microvascular rarefaction may be a long-term 
consequence of the insulin resistance rather than a cause. 
1.5.2.5.2 Capillaries Permeability 
Trans-endothelial transport of insulin may also be implicated in the delivery of 
insulin to the muscle interstitium (Barrett 2009). Whether the movement of 
insulin through the endothelium is a passive or an active process is still a source 
of some controversy (King 1985, Steil 1996, Hamilton-Wessler 2002, Wang 
2006). However, increase in vasopermeability to macromolecules of the skeletal 
muscle would result in an increase diffusion of the insulin to the interstitium, 
and therefore augment its effectiveness on the myocytes glucose uptake. 
Assessment of extravasation of albumin-bound Evans Blue in different models 
of insulin resistance was done to verify if impairment is present during insulin 
resistance. Extravasation of Evans Blue was shown to be decrease by 56 % after 
a 4 weeks high fructose feeding, compared to the ND (Chakir 1998). 
Interestingly, treatment with the insulin sensitiser Rosiglitazone has beneficial 
effect on the capillary permeability, with a ~40 % increase in extravasation of 
Evans Blue (St-Pierre 2004). However, it is not clear if change in permeability is 
a cause or a consequence of insulin resistance. Experiments in the obese Zucker 
rat showed a 30-50 % increased in capillary permeability when compared to 
their lean counterpart (St-Pierre 2006). This may therefore be an adaptive 
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mechanism compensating the loss of NO-dependent vasodilation and capillary 
recruitment noted in this model (Wallis 2002). Therefore, it is unlikely that 
capillary permeability is a key player in the initial stage of insulin resistance. 
1.6 EXERCISE-MEDIATED METABOLIC AND 
HEMODYNAMIC EFFECTS 
During exercise, turnover of ATP in skeletal muscle increases greatly, supported 
by metabolism of the glycogen and fatty acid stores, as well as enhanced 
utilisation of blood glucose. While relatively minor during the initial stage of 
contraction, contribution of blood glucose becomes more substantial as exercise 
continues and muscle glycogen stores are depleted. As with insulin, exercise-
mediated glucose uptake involves the translocation of the GLUT-4 transpo1ter to 
the plasma membrane and the T-Tubule (Roy 1996, Jessen 2005, Rose 2005). 
Interestingly, insulin- and exercise-mediated increases in glucose uptake are 
additive, meaning that they recruited distinct pools of GLUT4 transporter in the 
cells (Douen 1990). 
To sustain the contraction, an increase in the delivery on nutrient and 0 2 is 
required. Increase in microvascular recruitment occurs almost immediately after 
the initiation of contraction, preceding even the increase in total blood flow 
(Vincent 2006), and occurs at low intensities of muscle activity (Vincent 2006). 
The exact mechanisms responsible for the initial rise in blood flow are poorly 
understood, but appear to involve a local response from the capillaries 
themselves (Segal 2000) and/or from the mechanical stimulation of the 
contracting muscle, known as the muscle pump (Sheriff 1993). Thereafter, 
substance released from the contracting muscle, which included adenosine, 
potassium ions, acetylcholine, nitric oxide, and prostacyclin (reviewed in 
(Clifford 2004)), will induced a vasodilation of the feeding arteries, thus insuring 
a proper delivery of nutrient to sustain the contraction. The amplitude of the 
blood flow increase is proportional to the metabolic activity (Joyner 2007). 
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Exercise can be successfully used as a prevention treatment for development of 
obesity and TIID (Henriksen 2002, Anthony 2009) and to improve insulin 
sensitivity by ameliorating the vasodilatory dysfunction (De Filippis 2006). In 
insulin-resistant humans, insulin-stimulated skeletal muscle glucose transport 
has been shown to be improved in response to acute exercise (Minuk 1981, 
Hubinger 1987, Henriksen 2002) while both whole body and muscle glucose 
disposal are improved with aerobic exercise training (Hughes 1993, Dela 1995, 
Perseghin 1996, Henriksen 2002). 
1.7 SUMMARY AND THESIS AIMS 
The vascular actions of insulin, and more specifically its effects on 
microvascular recruitment, are an essential component of insulin's metabolic 
actions. In particular, the effect of insulin on skeletal muscle recruitment, which 
is responsible for ~50 % of insulin-mediated glucose disposal, is pertinent in 
assessing the progression of insulin resistance. 
The work presented herein was therefore designed to investigate whether 
impairment in insulin's ability to increase microvascular recruitment is an early 
event in the pathogenesis of insulin resistance. Establishing this is important to 
understand the pathophysiology of insulin resistance. This thesis has used two 
different models of impaired recruitment and insulin resistance to investigate the 
progression of insulin resistance. Firstly, insulin-mediated microvascular 
recruitment was assessed for the first time, in a pre-diabetic model of insulin 
resistance, the 4 weeks high-fat diet fed rat. This model was used to determine 
changes in microvascular recruitment during the early stage of insulin resistance 
and its functional response to insulin and contraction. Secondly, partial blockage 
of skeletal muscle microvasculature with 15 µm diameter latex microspheres 
was used to occlude terminal arterials and enable determination of the effects of 
a decreased muscle microvascular recruitment on insulin sensitivity. 
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The aims of this thesis are: 
1) To determine if an impairment in insulin-mediated microvascular 
recruitment is present in a pre-diabetic model of insulin resistance. 
2) To assess the effect of contraction on muscle glucose uptake and 
microvascular recruitment in a pre-diabetic model of insulin-resistance 
3) To develop a model of decreased microvascular recruitment using 
microsphere occlusion of the vasculature in order to evaluate the 
involvement of the microvasculature in insulin-mediated skeletal muscle 
glucose uptake in vivo. 
4) To determine if a chronic reduction in insulin-mediated microvascular 
recruitment could be responsible for the insulin resistance in the myocyte 
observed in late stage of type 2 diabetes. 
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2.1 ANIMAL CARE 
All experiments were conducted on male Hooded Wistar rats reared in the 
University of Tasmania animal house. Animals were housed in a 12h light/dark 
cycle at a constant temperature of 21 ± 1 °C and allowed free access to water. 
For experiment requiring the determination of whole body glucose kinetics, rats 
were fasted. Food was removed around 5:00 PM on the evening before the 
study. All procedures were approved by the University of Tasmania Ethics 
Committee. 
2.1.1 High-Fat Diet 
A diet in high-fat content was purchase from Specialty Feeds (SF03-002, Glen 
Forrest, WA, Australia). Table 1 shows the comparison of the characteristics 
between the high-fat diet (HFD) with the chow routinely used in our facility 
(ND; Gibsons, Hobart). In the HFD, 60% of the energy comes from fat, 
consisting of mainly saturated and monounsaturated fat. The increase in the fat 
content was made at the expense of the carbohydrate content. The protein 
proportion was constant in both diets. 
Table 1: Characteristics of the normal diet and the high-fat diet. 
Normal Diet High-Fat Diet 
% Total % Weight % Total % Weight Energy Energy 
Carbohydrate 71% 72% 26% 35% 
Protein 19% 19% 14% 19% 
Lipid 10% 5% 60% 36% 
%SAT 21 % Total lipid 60% Total lipid 
%MONO 42% Total lipid 33% Total lipid 
%POLY 37% Total lipid 7% Total lipid 
Total 100% 96% 100% 90% 
Sat: Saturated lipid, MONO: Monosaturated lipid, POLY: Polysaturated lipid. 
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The HFD was kept at 4 °C to prevent oxidation of the fatty acids and to ensure 
proper conservation. The diet contained all essential vitamins and nutrients. 
For dietary intervention experiments, five week old male Hooded Wistar rats 
weighting approximately 110 grams were split into two groups. Each group was 
placed on a 4 week feeding of either the HFD or ND. All animal prior to the 
nutritional intervention received the ND. 
2.2 IN VIVO EXPERIMENTS 
2.2.1 Surgery 
In vivo experiments were carried out in anaesthetized rats (50mg/100g body 
weight of pentobarbitone sodium) as shown in Figure 5. A 2 cm incision was 
made in the skin of the ventral side of the neck to allow access to the trachea and 
the neck vessels. A tracheotomy tube was inserted to facilitate spontaneous 
breathing during experiment. Polyethylene cannulas (PE60, Microtube 
Extrusions, North Rocks, NSW, Australia) were inserted in both jugular veins 
and secured using silk ligature (size 3/0 braided silk wax, Pearsalls Limited, 
England). The right jugular vein was used for the continuous infusion of 
pentobarbital and the left jugular was use to intravenously administer the various 
solutions required in the different experimental protocols. The right carotid 
artery was cannulated to monitor the arterial blood pressure using a pressure 
transducer (Transpac IV, Abbott Critical Systems, Morgan Hill, CA, USA), and 
was also used for arterial blood sampling. 
The femoral vessels in both limbs were exposed via a small incision ( ~ 1.5 cm) in 
the overlaying skin. The epigastric vessels were then either ligated or used for 
the local injection of MS (see section 5.2.2 for more details). An ultrasonic 
probe (Transonic Systems, VB series 0.5 mm Ithaca, NY, USA) was positioned 
around the femoral artery just distal to the rectus abdominis muscle. The cavity 
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in the leg surrounding the probe was filled with lubrication jelly (H-R, Mohawk 
Medical Supply, Utica, NY, USA) to provide acoustic coupling to the probe. 
The probe was connected to the flow meter (Model Tl 06 ultrasonic volume flow 
meter, Transonic systems, Ithaca, NY, USA). This was in tum interfaced with an 
IBM compatible PC computer that acquired the data (at sampling frequency of 
100 Hz) for femoral blood flow, heart rate and blood pressure using WINDAQ 
data acquisition software (DATAQ Instruments, Akron, OH, USA). The surgical 
procedure generally lasted approximately 40 min. The animals were maintained 
under anaesthesia for the duration of the experiment using a continuous infusion 
of pentobarbital sodium (0.6 mg/min/kg). The femoral vein of the left leg was 
used for venous sampling, using an insulin syringe with an attached 29G needle 
(Becton Dickinson, USA). The body temperature of the animal was maintained 
at 35 °C using a water-jacketed platform and a heating lamp positioned above 
the rat. 
For experiments exploring local effects, a second flow probe was positioned on 
the contralateral leg. Otherwise, only the right leg was assessed for total blood 
flow. 
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Carotid artery 
cannul ati on 
Jugular vein 
cannulat ion 
vein 
Figure 5: Schematic drawing of the in vivo surgery. 
Surgery details are given in section 2.2.1. Briefly, the neck surgery involved the 
insertion of a tracheotomy tube to facilitate the spontaneous breathing and the 
cannulation of one carotid artery and both jugular veins to enable the blood 
sampling and the various intravenous infusions. The lower leg surgery involved 
the positioning of a Transonic flow probe around one or both of the femoral 
arteries to measure the femoral arterial blood pressure and, in the experiments 
requiring a local injection, the epigastric artery was cannulated. Diagram adapted 
from Mahajan et al. (Mahajan 2004). 
2.2.2 Isoglycaemic Hyperinsulinaemic Clamp 
Once the surgery was completed, a 60 min equilibration period was allowed so 
that leg blood flow and blood pressure could stabilise (Figure 6). Two arterial 
samples were taken at the end of equilibration and at regular intervals 
throughout the experimental procedure. Insulin (Humilin , Lilly, USA) was 
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infused at a rate of 10 mU/min/kg of body weight during which blood glucose 
was maintained at isoglycaemia by infusion of a 30 % w/v solution of glucose. 
The insulin dose of 10 mU/min/kg of body weight was chosen to increase the 
insulinaemia to a high but physiological level. In control groups, saline infusion 
was matched to the volumes of insulin and glucose infused during the clamp. 
At the end of the experiment, arterial and venous samples were collected (800 µl 
each). Blood glucose was measured on the arterial sample and plasma glucose 
was measured on both samples. Two 100 µl aliquot of each plasma sample were 
mixed with 20 µl of 2 M perchloric acid to precipitate proteins. Treated samples 
were later used to assess 1-methylxanthine (1-MX) concentration. Muscles from 
the right calf (soleus, plantaris, gastrocnemius red, gastrocnemius white, 
extensor digitorum longus and tibialis) were individually removed and 
immediately frozen in liquid nitrogen. Muscles were kept at -80 °C until assayed 
for 2-deoxyglucose (2-DG) uptake. 
Bolus Bolus 
Allopurinol 2-DG A-V 
(10 µmol/kg) (50µC1) 
.1EJ 
@ @@@@ @ @ 
Time • • • • • • • • • • • • (mm) I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
-60 -40 -20 0 20 40 60 80 100 120 
I Saline or Insulin infusion (10mU/min/kg) 
I Variable 30% glucose 
I 1-MX (0.4 mg/min/kg) 
Figure 6: Isoglycaemic hyperinsulinaemic clamp. 
Venous infusions are indicated by the bars. Bolus injections are shown by @. 
Blood glucose was measured in arterial samples at the times indicated by •. 
Arterial samples for the determination of radioactivity are shown by @ and 
arterial and venous samples were collected for HPLC analysis at the time 
indicated by ..IEJ. 
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2.2.3 Experimental Procedures 
2.2.3.1 Analytical Methods 
Blood and plasma glucose were determined using a glucose analyser by the 
glucose oxidase method (Model 2300 Stat plus, Yellow Springs Instruments, 
OH, USA). A sample of 25 µl was required for each determination. Enzyme 
immunoassay ELISA was used to assess the plasma level of insulin (Mercodia 
AB, Sweden) and TNF-a (Thermo Scientific, USA). 
2.2.3.2 Hindlimb Glucose Uptake 
To measure the glucose uptake across the lower hindlimb, glucose levels were 
determined in both arterial sample and venous sample from the femoral vessels, 
which drains blood from the lower leg. Hindlimb glucose uptake (HGU) was 
measure by the blood glucose arterio-venous difference multiplied by the 
femoral blood flow, and expressed as µmol/min. 
2.2.3.3 2-Deoxyglucose Uptake 
Muscle glucose uptake was measured using a modified vers10n of the 2-
deoxyglucose (2-DG) uptake technique (Kraegen 1985). Forty-five minutes 
before the completion of the experiment, a 200 µl bolus of 2-deoxy-d-[1-
14C]glucose (0. lmCi/ml, Sigma) was injected via of the jugular vein. Arterial 
samples were collected at 5, 10, 15, 30 and 45 min to determine plasma 
clearance of the radioactivity. The plasma samples (25 µl) were then added to 4 
ml of Biodegradable Counting Scintillant-BCA (Amersham Pharmaca Biotech, 
IL, USA) and glucose radioactivity was determined using a scintillation counter 
(Perkin Elmer Inc, Tri-Carb 2800TR, IL, USA). 
At the end of the experiments, calf muscles (soleus, plantaris, gastrocnemius red, 
gastrocnemius white, extensor digitorum longus and tibialis anterior) were 
collected and were immediately freeze-clamped using liquid nitrogen-cooled 
tongs. Muscles were kept at -80°C until assayed for 2-DG uptake. 
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The frozen muscles were ground under liquid nitrogen and 100 mg of muscle 
tissue was homogenized with 1.5 ml of water using a Heidolph ™ silent crusher 
M (26000 RPM). Free and phosphorylated [14C]2-DG were separated by ion 
exchange chromatography using an anion exchange resin (AG1-X8, Bio-Rad 
laboratories, CA, USA). Biodegradable Counting Scintillant (16 ml) was added 
to each radioactive sample and radioactivity determined using a scintillation 
counter (Perkin Elmer Inc, Tri-Carb 2800TR, IL, USA). From this measurement, 
and knowledge of plasma glucose and the time course of plasma 2-DG 
disappearance, glucose uptake into the muscle (R' g) was calculated as 
previously described by others (Kraegen 1985) and expressed as µg/g/min. The 
R' g for the combined muscle was calculated from the sum of R' g of each 
individual muscle multiplied by the wet weight of the individual muscle and 
divided by the sum of each individual muscle wet weight. 
2.2.3.4 Whole Body Glucose Kinetics (Ra & Rd) 
To determine the glucose turnover (rate of appearance and rate of disappearance 
of glucose), a prime (2 µCi), continuous infusion of 3-[3H]-D-glucose (0.1 
µCi/min, specific activity of 16.6 Ci/nmol, Sigma) was administered along with 
the insulin/saline infusion. Arterial samples were taken 15 min prior to, and on 
completion of the experiment, centrigugated and the plasma removed. The 
plasma was then deproteinised using 2 M PCA, evaporated to dryness to remove 
3H20 and re-suspended in distilled water. Biodegradable Counting Scintillant 
was added to each sample and [3H] glucose radioactivity was determined using a 
scintillation counter. The rate of appearance (Ra) and disappearance (Rd) of 
glucose were calculated using the isotope dilution equation: 
Ra+ GIR =Rd= F/SA 
Where: 
GIR = glucose infusion rate 
F = rate of tracer infusion 
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SA = specific activity of glucose, calculated by dividing the plasma 
radioactivity by the glucose concentration. 
The hepatic glucose production (Ra) was then calculated by subtracting the 
glucose infusion rate from the Rd as previously described (Bumol 1983). 
2.2.3.5 1-MX Metabolism 
For the assessment of the microvascular recruitment, a biochemical assay using 
an intrinsic property of the capillary beds was used (Rattigan 1997). Xanthine 
oxidase (XO) is an enzyme present at the luminal surface of capillaries and is 
practically absent from the bigger vessels (Jarasch 1986, Parks 1986). Thus, by 
using an infusion of a specific substrate of XO, 1-methylxanthine (1-MX) 
(Sigma, USA), the perfused capillary surface area can be assessed. In perfused 
capillaries, 1-MX will be converted by XO to 1-methylurate (1-MU). An 
increase in the microvascular recruitment will result in an increase conversion of 
1-MX to 1-MU. Therefore, the 1-MX disappearance will be proportional to the 
surface area perfused. 
Since 1-MX clearance is very rapid, it was necessary to partially inhibit the XO 
activity to obtain a constant arterial 1-MX concentration. Therefore, a bolus dose 
of allopurinol (ALP, lOµmol/kg) was administered via the carotid artery 5 min 
prior to commencing the 1-MX infusion (0.4 mg/min/kg). This allowed a 
constant arterial concentration of approximately 15-25 µM of 1-MX to be 
maintained throughout the experiment. 
Perchloric acid-treated plasma samples collected at the end of the experiment 
were centrifuged for 10 min. The supematants were used to determine 1-MX, 1-
1-MU and oxypurinol concentrations by reverse-phase high-performance liquid 
chromatography (HPLC) (using Gemini 5 µm C18, 255 x 4.6 mm column 
(Phenomenex, USA)) as described previously (Rattigan 1997). The 1-MX 
metabolism in nmol/min was calculated from the following equation: 
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1-MXD = ([1-MX]a - [1-MX]v) * 0.871 * FBF 
Where [1-MX]a and [1-MX]v are the plasma 1-MX concentration (µmol/L) 
obtained from arterial and venous blood samples respectively, 0.871 is the factor 
to convert the 1-MX concentration measured in plasma to that in whole blood, 
FBF is the femoral blood flow rate (ml/min) measured at the end of the 
experiment. 
2.2.3. 6 Xanthine Oxidase Activity Assay 
XO activity was assessed from muscle homogenates as described previously 
(Rattigan 2001 ). 400 mg of muscle were homogenised in the 2 ml of 
Homogenising buffer (50 mM Na2HP04, 0.1 mM EDTA, 4 mM dithiothreitol 
and 0.5 mg/ml Trypsin Inhibitor at pH of 7.4). Samples were centrifuged at 
50000 g at 10 °C for 30 min (Sorvall WX Ultra 90 centrifuge, Thermo Electron 
Corporation, USA). Proteins were separated on a PD-10 desalting column 
(Amersham Pharmacia Biotec, USA) and fractions of 1 ml were sequentially 
collected. Fraction #5 contained the proteins and was then used for the assay. A 
100µ1 sample of the protein fraction #5 was added to 900 µl of Assay buffer 
(Homogenising buffer with 0.1 mM Xanthine). Mixes were incubated for an 
hour at 3 7 °C, after which the reaction were stopped by adding 250 µl of the 
assay mix to 50 µl of 2 M PCA. Uric acid contents were then measured by 
HPLC (using Gemini 5 µm C18, 255 x 4.6 mm column (Phenomenex, USA) 
with 50 mM NH4H2P04 buffer (pH 3.5) at a flow of 1.2 ml/min)). The protein 
content of each of the reaction solution was measured by the Bradford assay 
(Bio Rad, USA). Activity was expressed as amount of uric acid from per mg of 
protein per minutes. 
2.2.3. 7 Contrast-Enhanced Ultrasound 
Contrast Enhanced Ultrasound (CEU) imaging of the muscle microvasculature is 
a recently developed technique adapted from its use in cardiovascular imaging 
(Wei 1998). Gas filled phospholipid microbubbles (see section 2.2.3.7.1) were 
infused intravenously into systemic circulation at a constant rate of 45 µl/min 
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and visualised using a linear array transducer/probe (L7-4) interfaced with an 
ultrasound system (HDI-5000; Phillips Ultrasound, USA). The probe was 
positioned over the left hindleg of the rat to allow imaging of the proximal 
adductor muscle groups (adductor magnus and semimembranosus) (Armstrong 
1983). The microbubbles have a similar rheology to erythrocytes, enabling them 
to stay in the microvasculature and act as a marker of microvascular space 
(Lindner 2002). The microbubbles are echogenic and as they pass under the 
ultrasound beam, they can be simultaneously imaged and destroyed. The 
velocity at which the microvasculature fills and the amount of volume perfused 
can be measured by controlling the amount of time between pulses. The 
mechanical index, a measure of acoustic power, was set to 0.8. The acoustic 
focus was set at the mid portion of the muscles and the gain settings were 
optimised and maintained through each separate experiment. The pulsing 
intervals were set at 0.2, 0.3, 0.5, 1, 2, 3, 5, 8, 12, 15, 20 and 25 sec. At each 
pulsing interval, 3 frames were captured and the signal/intensity from these 
frames was averaged. The signal from the larger vessels and background were 
subtracted and the pulsing interval curve was constructed by plotting pulsing 
intervals time versus acoustic intensity (Figure 7). 
At the conclusion of the experiment, the data is analysed using Qlab advanced 
quantification software (Phillips Medical Systems, Netherlands). A region of 
interest was selected to include only proximal adductor muscle groups. This 
software gives a measure of the received ultrasound signal (in decibels) in the 
selected region of interest. This value is then converted to acoustic intensity (AI) 
by the equation: AI = 1 Qi'( decibels/I 0). Thus, using these values, we are able to 
subtract the signal intensity from the larger vessels and the background image, 
from the signal of the smaller vessels to gain a true measure of microvascular 
perfusion. Smaller time interval (0.07-0.5 s) represent the microbubble fill time 
of the larger vessels, while the longer pulsing intervals (20-25 s) represent the 
microvasculature volume. Subtraction of the shorter time interval, where only 
the bigger vessel would have had time to refill after the acoustic burst, enable the 
measurement of only the microvascular space. The vascular volume and the rate 
of filling can be determined by using the following equation: 
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Y is the acoustic intensity (Al), A is the microvascular blood volume, p is the 
microvascular flow rate. Microvascular blood flow can be calculated by 
multiplying the microvascular blood volume by the microvascular flow rate (A* 
p). 
A value (volume) 
y =A (1-e·fit) 
Pulsing interval (s) 
Figure 7: Micro vascular blood volume and flow rate. 
Once a pulsing interval curve has been constructed, the plateau position (A) 
represents a measure of microvascular blood volume, and the rate of increase (p) 
represents a measure of average filling rate of the microvasculature. By 
multiplying A and p, a measure of microvascular blood flow can be determined. 
Figure adapted from (Ross 2008). 
2.2.3. 7.1 Microbubbles Contrast Agents 
The phospholipid microbubble solution was prepared in the laboratory. 
Material per lOOml: 
10.35 g Propylene glycol 
12.62 g Glycerol 
0.66 g NaCl 
75 mg Lipid blend consisting of: 
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- 4.3 mg DPP A (l ,2-dipalmitoyl-sn-glycero-3-phosphatidic acid, 
monosodium salt) 
- 39 mg DPPC (l,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine) 
- 30.7 mg MPEG5000-DPPE (N-(methoxypholyethylene glycol 
5000 carbomyl)- 1,2-dipalmitoyl-sn-glycero-3-
phosphatidylanolamine, monosodium salt 
The propylene glycol was heated in a 75 °C water bath in 200 ml beaker 
(covered with aluminium foil to prevent evaporation). The lipid blend was added 
to the propylene glycol when it has reached 75 °C (about 30 min). In a separate 
beaker, NaCl was dissolved in 60 ml of distilled water and added to glycerol 
before being heated to 75 °C. When dissolved, the lipid blend/propylene glycol 
was added to the NaCl/glycerol and dissolved in 75 °C water bath (about 60 
min). The pH of the solution was adjusted to 6.5 using NaOH or HCl and filled 
to volume (100 ml) with distilled water. The solution was filtered through a 
sterilising filter (0.45µm) into sterile falcon tubes before 1.5 ml of solution was 
transferred into 5 ml vials. The head space was exchanged for octafluoropropane 
gas, the vials were sealed, and stored at 4 °C. 
2.2.3.8 High-Energy Intermediates Determination by HPLC 
Creatine compounds (Creatine and Creatine Phosphate) and adenine nucleotides 
(ATP, ADP, AMP) were determined by HPLC as previously described by Ye et 
al. (Ye 1996). Approximately 100 mg of muscle was added to 1.5 ml of ice cold 
0.42 M of PCA. The samples were mixed by three quick vortex spin. Samples 
were then centrifugated for 5 min at 5000 RPM at 4 °C. One ml of the 
supernatant was removed and 220 µl of 1 M K2C03 was added. Samples were 
kept on ice for 30 min to ensure the total neutralisation of the PCA. A final 5 
min centrifugation at 5000 RPM was made to collect the supernatant, which was 
then used to measure the high-energy intermediates content by HPLC. 
A Gemini 5 µm Cl8 column was used (Phenomenex, USA) for HPLC and peaks 
detected with ProStar 330 Photodiode Array Detector (Varian Analytical 
Instruments, USA). Compounds were eluted from the column using a 
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combination of two buffers, buffer A (174 mM of NH4H2P04, 1.76 mM of 
TBAHS) and buffer B (10% acetonitrile added to buffer A), in the following 
sequence: 
- 0-3 min: 100% ofbuffer A 
- 3-30 min: gradual increase of buffer B until it represented 80% of the 
buffer mix used at 3 0 min 
- 30-40 min: 100% of buffer A. 
Creatine compounds were detected by absorbance at 214 nm, and adenine based 
compounds by absorbance at 254 nm. Analysis of the peaks was done using the 
VarianStar programs suite (Varian Analytical Instruments, USA). 
To measure the ratio of dry weight/wet weight, 100 mg of each muscle were 
dried in a 70 °C oven for 24 hours. The high-energy intermediates content was 
then expressed as µmol per gram of dry weight. 
2.2.4 Hemodynamic Data Analysis 
All data are expressed as means ± SEM. Mean arterial pressure, mean heart rate 
and mean femoral blood flow were calculated using five seconds sub-samples of 
WINDAQ data, which represented 501 flow and pressure measurements. These 
measurements were taken every 10 or 15 min during the experiment. 
2.2.5 Statistical Analysis 
Differences between basal and final values were assessed using a paired t-test. 
Comparisons were made between treatment groups over the course of the 
experiment using two-way repeated-measures ANOVA with Student-Newman-
Keuls (SNK) post hoe test. The differences between treatment groups were 
examined using one-way ANOV A, repeated measures ANOV A or t-test as 
indicated in each chapter. All tests were performed using the SigmaStat 
statistical program (Systat Software Inc, CA, USA). 
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3.1 INTRODUCTION 
The incidence of obesity and type 2 diabetes are on the rise in the western world 
(ABS 2008, ADA 2009, WHO 2009). Both pathologies are characterized by an 
impairment of insulin action (Jonk 2007). The skeletal muscle is an extremely 
important organ in insulin-mediated glucose disposal, as it accounts for about 80 
% of the insulin-mediated glucose uptake after a meal (Defronzo 1988). In 
addition, muscle insulin resistance is a precursor to the hyperglycemia observed 
in patients with glucose intolerance or type 2 diabetes (Reaven 1988, Defronzo 
1991) underscoring the contribution of the skeletal muscle to the insulin resistant 
phenotype. Therefore, skeletal muscle is a prime target for the early defects in 
the development of insulin resistance, although the exact mechanism remained 
largely unknown. 
Nearly two decades ago, insulin was shown to possess vascular action during the 
euglycemic hyperinsulinaemic clamp (Laakso 1990). Since then, insulin was 
shown to increase the muscle microvascular recruitment (Rattigan 1997) and as 
such increase the delivery of hormones and nutrients to this tissue. Moreover, 
acute impairment of the vascular effect of insulin leads to a ~50% decrease in 
the insulin-mediated glucose disposal (Youd 2000). Studies have shown that 
insulin-mediated microvascular recruitment is impaired in type 2 diabetes 
(Wallis 2002) and obesity (Clerk 2006). What remains unknown is how the 
microvascular recruitment relates to the development of insulin resistance. Other 
groups have suggested that a defect in glucose delivery and/or transport is/are 
the major causes of dietary insulin resistance (Fueger 2007). 
Animal models present a very interesting avenue to understand the pathogenesis 
of type 2 diabetes. Rodents can develop a state of insulin resistance and diabetes 
by many means: pharmacological intervention (Ziel 1988, Sato 1996, Roy 1998, 
Vincent 2003, Bradley 2006), genetic modifications (Araki 1994, Bruning 1997, 
Stenbit 1997, Kulkarni 1999, Mauvais-Jarvis 2000, Zisman 2000), and 
nutritional intervention (Kraegen 1986, Storlien 1991, Han 1997, Hansen 1998, 
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Kim 2000). When choosing a model, one must keep in mind how closely the 
pathogenesis resembles the human disease studied. Not only the phenotype must 
be as close as possible, but the induction process should be faithful to the human 
disease. In that context, nutritional intervention presents the most interesting 
method. 
It has been known for years that a diet rich in fat, particularly in animal or 
saturated fat, can produce a state of insulin resistance (Masek 1959) and obesity 
over a prolonged period (Han 1997, Buettner 2007). The 4 week high-fat diet 
(HFD) fed rats has been repeatedly used in the literature as a pre-diabetic model 
of insulin resistance, characterized by a hyperinsulinemia with only mild 
changes in glucose homeostasis (Masek 1959, Kraegen 1986, Han 1997, 
Koshinaka 2004, Buettner 2007). HFD also induced an impairment of the 
insulin-mediated skeletal muscle glucose uptake (Han 1997) as well as an 
impairment of the insulin-mediated suppression of hepatic glucose output 
(Kraegen 1991). Furthermore, the HFD has been shown to induce vascular 
dysfunction within 1-2 weeks of the feeding (Youngren 2001, Kim 2008). 
Thus, the aim of this study was to assess if the pre-diabetic state is characterized 
by an early impairment of the insulin-mediated microvascular recruitment. Such 
a decrease in nutrient and insulin delivery to the skeletal muscle may be 
responsible for the apparition of whole body insulin resistance in the later stage 
of type 2 diabetes. 
3.2 MATERIALS AND METHODS 
3.2.1 Animal Care 
Hooded Wistar rats were raised as described in section 2.1. They were divided 
into two groups: one group received the normal diet (ND), while the other group 
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received the HFD. Table 1 shows the content of the different diets. Rats were 
fasted overnight before experimentation to enable the determination of whole 
body glucose kinetics as described in section 2.2.3.4. 
3.2.2 In vivo Experiments 
In vivo experiments were carried out in anaesthetised rats as described in section 
2.2.1. Briefly, I-hour after the surgery procedure, saline or insulin (10 
mU/min/kg) was infused into the rat and continued for 2 hours (Figure 6). 
During experiments involving insulin infusion, a glucose solution (30 % w/v) 
was also infused at variable rates to maintain blood glucose levels around basal 
levels. Femoral artery blood flow (FBF) was continuously measured using a 
Transonic® flow probe positioned around the femoral artery of the right leg. 1-
MX metabolism was used as an indicator of perfused capillary surface area as 
described in section 2.2.3.5. A bolus dose of [3H]2-DG (50 µCi) was given 45 
min before the end of the experiment. Calf muscles were excised at the 
completion of the experiment and freeze clamped in liquid nitrogen to assess the 
2-DG uptake as described in section 2.2.3.3. Enzyme immunoassay ELISA was 
used to assess the plasma level of insulin (Mercodia AB, Sweden) and TNF-a 
(Thermo Scientific, USA). 
3.2.3 Xanthine Oxidase Activity 
Xanthine oxidase activity was assessed in muscle homogenates as described in 
section 2.2.3.6. 
3.2.4 Data Analysis 
All data are expressed as means ± SEM. Data were calculated as described in 
section 2.2.4. Differences between basal and final values were assessed using a 
paired t-test. Comparisons were made between treatment groups over the course 
of the experiment using two-way non-repeated or repeated-measures ANOVA 
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with Student-Newman-Keuls post hoe test as indicated in the figure legends. All 
tests were performed using the SigmaStat statistical program (Systat Software 
Inc, CA, USA) 
3.3 RESULTS 
3.3.l Characteristics of the High-Fat Diet Fed Rats 
Table 2 shows the characteristics of rats fed the ND or the HFD for 4 weeks. 
HFD fed animals showed an increase in total body mass and in epididymal 
adipose tissue mass, with a decrease in hindleg muscle mass (Table 2). As 
expected, HFD feeding induced a state of insulin resistance as seen by a 
significant increase in fasting plasma glucose (ND= 5.28 ± 0.14 mM vs. HFD = 
5.91 ± 0.21 mM, p<0.05) and plasma insulin (ND= 66 ± 8 pmol/L vs. HFD = 
112 ± 12 pmol/L, p<0.01). In the ND fed animal, plasma insulin levels were 
significantly higher after the insulin infusion (ND-Saline= 71 ± 12 pmol/l vs. 
ND-Insulin = 975 ± 81 pmol/l, p<0.05). Similarly, in the HFD fed animal, 
insulin was significantly increased following the insulin infusion (HFD-Saline= 
114 ± 13 pmol/l vs. HFD-Insulin = 1280 ± 241 pmol/l, p<0.05). The magnitude 
of the increase in endpoint plasma insulin was similar in both diet groups (Figure 
8). 
Plasma TNF-a in samples from both groups were assayed but levels were below 
the detection range of the ELISA assay. Other studies have also failed to observe 
an increase in systemic level of TNF-a after 4 weeks of HFD feeding (Kim 
2008, Chatterjee 2009). 
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Table 2: Characteristics of Normal Diet or High-Fat Diet Fed Rats. 
Normal Diet High-Fat Diet 
Body weight (g) 231±1 241±3 * 
Epididymal fat pad (g) 0.92 ± 0.04 2.45 ± 0.16 ** 
Leg muscle mass (g) 2.04± 0.02 1.93 ± 0.03 ** 
Fasting plasma glucose (mmol/l) 5.28 ± 0.14 5.91±0.21 * 
Fasting plasma insulin (pmol/l) 66± 8 112 ± 12 ** 
Mean blood pressure (mmHg) 105 ± 2 107±2 
Heart rate (BPM) 336 ± 10 332± 8 
Femoral blood flow (ml/min) 0.92 ± 0.04 0.87 ± 0.05 
Data are means± SE for n = 15-19 rats in each group. * p<0.05, ** p<0.01 vs. 
ND. Epididymal fat pad and leg muscles (Soleus, plantaris, grastrocnemius, 
EDL, tibialis) were removed from rats at the completion of the experiment. All 
other values were measured prior to the commencement of saline or insulin 
infusion. 
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Figure 8: Plasma insulin before (Fasting) and at the completion of the 
experiment (Endpoint). 
Data are means± SEM for n = 6-10. * p<0.05 from saline of corresponding diet, 
# p<0.05 from ND. 
o ND-Saline, HFD-Saline, •ND-Insulin, • HFD-Insulin. 
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3.3.2 Hemodynamic Parameters 
HFD feeding had no effect on the basal blood pressure, heart rate or FBF (Table 
2). Mean arterial pressure and heart rate were constant and unaffected by the 
different treatments (Figure 9). HFD fed rats had a significant impairment of the 
insulin-mediated increase in FBF (Figure 10). FBF in the ND was significantly 
increased from basal levels after 30 min of insulin infusion, while significant 
increases in FBF only occurred in the HFD animals after 50 min. Although a 
significant fold change in FBF still occurred with the HFD animals (Figure 1 OB) 
at the later stage of the insulin clamp, the increase was significantly less than in 
the ND (ND= 0.75 ± 0.06 ml/min vs. HFD = 0.43 ± 0.11 ml/min, p<0.05). 
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Figure 9: Mean arterial blood pressure and heart rate. 
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Time course for mean arterial pressure (A) and heart rate (B) as a result of a 
saline or insulin infusion in rats fed a ND or HFD for 4 weeks. Data are means ± 
SEM for n = 6-10. 
ti ND-Saline, .A. ND-Insulin, HFD-Saline, ~ HFD-Insulin 
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Figure 10: Femoral blood flow and change in femoral blood flow. 
Time course for femoral blood flow (A) and change in femoral blood flow (B) as 
a result of a saline or insulin infusion in rats fed a ND or HFD for 4 weeks. Data 
are means ± SEM for n = 6-10. * p<0.05 from saline of corresponding diet, # 
p<0.05 from ND-insulin. 
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3.3.3 Metabolic Parameters 
Fasting blood glucose was significantly elevated in HFD fed rats compared to 
the ND and since the clamps were performed to maintain initial blood glucose 
levels, the blood glucose for the HFD animals were significantly higher at all 
times (Figure 1 lA). Whole body insulin sensitivity, reflected by the glucose 
infusion rate during the clamps, was significantly lower in HFD (~ -31 % at 120 
min, p<0.01) in comparison to ND (Figure 1 lB). Hindleg glucose uptake (Figure 
12A) and 2-DG uptake (Figure 12B) was blunted with high-fat feeding (~ -43 % 
p<0.01 and~ -21 % p=0.05, respectively) and there was no fibre type preference 
to the impairment (Figure 13). 
Assessment of the whole body glucose kinetics revealed that after a HFD insulin 
had blunted effects on both the decrease in Ra (ND-Insulin = 0.89 ± 0.51 
mg/min/kg vs. HFD-Insulin = 2.83 ± 0.34, p<0.01) (Figure 14A) and the 
increase in Rd (ND-Insulin= 18.29 ± 1.22 mg/min/kg vs. HFD-Insulin = 14.37 ± 
0.45, p<0.01) (Figure 14B). This is consistent with insulin resistance in both 
skeletal muscle and liver. 
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Time course for the glucose infusion rate (A) and the blood glucose 
concentration (B) as a result of a saline or insulin infusion in rats fed a ND or 
HFD for 4 weeks. Blood glucose levels were maintained at basal level (time 0 
min). Data are means ± SEM for n = 6-10. # p<0.05 from ND, two-way RM 
ANOV A with post-hoe analysis using SNK method. 
!::.. ND-Saline, .6.. ND-Insulin, HFD-Saline, T HFD-Insulin 
54 
CHAPTER 3: 
INSULIN-MEDIATED MICROV ASCULAR RECRUITMENT IS IMP AIRED 
IN PRE-DIABETIC ST A TE 
A Hindleg Glucose Uptake 
1.0 
* # 
0.8 
-r:: 
E 0.6 ::::: 
0 
E 
::i. 
- 0.4 ::::> 
(!) 
:::c 
0.2 
0.0 
Saline Insulin 
B Muscle Glucose Uptake (Combined Muscle) 
16 
* # 14 
-
12 
r:: 
E 10 
-Cl 
- 8 Cl 
::::1. 
-Cl 6 
tt: 4 
2 
0 
Saline Insulin 
Figure 12: Hindleg glucose uptake and muscle 2-deoxy-glucose uptake. 
Hindleg glucose uptake (HGU) (A) and muscle radioactive 2-DG uptake (R 'g) 
(B) for the combined calf muscle as a result of a saline or insulin infusion in rats 
fed a ND (• )or HFD (• )for 4 weeks. Data are means± SEM for n = 6-10. * 
p<0.05 from saline of corresponding diet,# p<0.05 from ND-insulin, using two-
way RM ANOV A with post-hoe analysis using SNK method. 
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Figure 13: Muscle glucose uptake in individual muscles. 
Tibia I is 
Muscle radioactive 2-DG uptake (R'g) for individual muscles of the lower leg as 
a result of a saline or insulin infusion in rats fed a ND or HFD for 4 weeks. Data 
are means ± SEM for n = 6-1 0. * p<0.05 from saline of corresponding diet, # 
p<0.05 from ND-insulin, using two-way RM ANOV A with post-hoe analysis 
using SNK method. (RG: red gastrocnemius, WG: white gastrocnemius, EDL: 
extensor digitorum longus) 
o ND-Saline, HFD-Saline, • ND-Insulin, • HFD-Insulin. 
56 
CHAPTER3: 
INSULIN-MEDIATED MICROV ASCULAR RECRUITMENT IS IMPAIRED 
IN PRE-DIABETIC ST A TE 
A Rate of Appearance 
7 
6 
-C> 5 
.:.:: 
-c 
E 4 * # 
-C> 
E 3 
-ta 
a:: 2 
1 
0 
Saline Insulin 
B Rate of Disappearance 
25 
20 * 
-C'I 
.:.:: 
-c 15 
E 
-C'I 
E 10 
-
"C 
a:: 
5 
0 
Saline Insulin 
Figure 14: Rate of appearance and disappearance. 
The rate of glucose appearance (hepatic glucose production (A)) and glucose 
disappearance (glucose uptake (B)) as a result of a saline or insulin infusion in 
rats fed a ND(• ) or HFD (• )for 4 weeks. Data are means ± SEM for n = 6-10. * 
p<0.05 from saline of corresponding diet, # p<0.05 from ND-insulin, using two-
way RM ANOV A with post-hoe analysis using SNK method. 
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3.3.4 Microvascular Recruitment 
Arterial level of oxypurinol was similar in all groups (NS). Arterial 1-MX 
tended to be higher in the HFD fed rats, and this increase was significantly in the 
HFD-Insulin group (Figure 15A). ND fed rats had the expected insulin-mediated 
increase in microvascular recruitment (ND-Saline = 5.83 ± 0.69 nmol/min vs. 
ND-Insulin= 9.98 ± 0.78 nmol/min, p<0.01) while this effect of insulin was lost 
in the HFD fed rats (HFD-Saline = 5.76 ± 0.77 nmol/min vs. HFD-Insulin = 7.34 
± 0.98 nmol/min, p=0.16) (Figure l 5B). Moreover, the insulin-mediated increase 
in the ND was significantly different from the level in the insulin clamp HFD 
rats (ND-Insulin = 9.98 ± 0.78 nmol/min vs. HFD-Insulin = 7.34 ± 0.98 
nmol/min, p<0.05). 
3.3.5 Xanthine Oxidase Activity 
The level of xanthine oxidase activity measured in tissue homogenates from the 
calf muscles was unaffected by the HFD (ND = 45.5 ± 2.8, HFD = 46.9 ± 8.3 
pmol/mg/min, p=0.86). 
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Figure 15: 1-MX arterial levels and disappearance. 
Arterial level of 1-MX (A) and 1-MX metabolism (B) as a result of a saline or 
insulin infusion in rats fed a ND (•) or HFD (• ) for 4 weeks. Data are means± 
SEM for n = 6-10. * p<0.05 from saline of corresponding diet,# p<0.05 from 
ND-insulin, using two-way RM ANOV A with post-hoe analysis using SNK 
method. 
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3.4 DISCUSSION 
The present study indicates that insulin-mediated microvascular recruitment is 
impaired in the pre-diabetic state and this is accompanied by a reduction in 
sensitivity to the insulin-mediated metabolic and macrovascular actions. These 
findings add important knowledge to the aetiology of the development of type 2 
diabetes, as this is the first time that the microvascular recruitment has been 
implicated in the early stage of the development of insulin resistance. These data 
suggest that impaired insulin-mediated microvascular recruitment could be an 
early event that in due course, could worsen the muscle insulin resistance. 
In the present study, the 4 week HFD induced a pre-diabetic state of insulin 
resistance, with a marked decrease in GIR (-31 %) associated with decrease 
hindleg (-21 %) and muscle specific (-43 %) glucose uptake. These results are 
consistent with other experiments using the HFD feeding model (Masek 1959, 
Kraegen 1986, Han 1997, Koshinaka 2004, Buettner 2007). The impairment of 
glucose metabolism was also accompanied with impairment of the vascular 
action of insulin on FBF and microvascular recruitment. The 4 weeks HFD has 
not only induced insulin resistance in the muscle, but also in the liver. Indeed, 
insulin inhibitory effect on the HGO is blunted following the high-fat diet. This 
is consistent with a previous study by Kraegen and colleagues, where 3 day of 
HFD feeding was shown to be sufficient to induced hepatic insulin resistance 
(Kracgcn 1991). 
The main finding of the present study is that the insulin-mediated microvascular 
recruitment was blocked with the HFD. As such, delivery of hormones and 
nutrients to muscle in response to insulin is impaired early in the progression of 
the disease. This impairment is likely to worsen the insulin resistance in the long 
term (Clark 2008) and agrees with studies suggesting that vascular insulin 
resistance precedes the peripheral insulin resistance (Youngren 2001, Kim 
2008). 
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Two main hypotheses are present in the literature to explain the mechanisms 
leading to insulin resistance and ultimately to type 2 diabetes. The first states 
that an increase in circulating FF A is the culprit (Boden 2002). FF A will then 
accumulate in non-adipose tissues such as muscle and liver. At the molecular 
level, fatty acid interferes with the intracellular insulin signalling by increasing 
intracellular concentration of fatty acid metabolites, fatty acyl Co-A, ceramides 
and diacylglycerol (DAG) (Shulman 2000, Machann 2004, Summers 2006). 
Interestingly, this impairment of the insulin signalling is similar in skeletal 
muscle and endothelium (Kim 2005). In accordance with this theory, 
microvascular recruitment has been shown to be blunted with increase 
circulation FF A (Clerk 2002), due to a decrease in NO production (Steinberg 
2000). Increase in FF A is unlikely to be the only signal responsible for the 
development of insulin resistance. Indeed, mice with adipocyte specific KO of 
GLUT-4 develops insulin resistance even though the circulating levels of FF A 
are decreased (Abel 2001). 
Secondly, the vasocrine hypothesis (Yudkin 2005) states that the development of 
insulin resistance results from an increase secretion of cytokine by the adipose 
tissue, either by the adipocytes per se or by infiltrated macrophages 
(Hotamisligil 2006). TNF-a, an inflammatory cytokine, has been shown to be 
elevated in obesity and type 2 diabetes and to interfere with the insulin 
signalling. This cytokine is known to impair insulin-mediated NO production 
from eNOS (Valerio 2006), which has been shown to be implicated in the 
microvascular perfusion (Vincent 2003). The insulin resistance present with the 
HFD resembles the conditions observed during an acute infusion of TNF-a 
(Youd 2000). Indeed, similar responses to a 10 mU insulin infusion on the GIR, 
HGU, R'g, FBF and 1-MX disappearance were obtained. However, systemic 
levels of TNF-a after 4 weeks HFD were not elevated. This is not unexpected, as 
evidence from the literature place impairment of the vascular action of insulin 
before the increase in circulating inflammatory cytokine (Kim 2008 20791 ). 
Although not increased systemically, local increase in TNF-a may still be 
responsible for the impairment of capillary recruitment following a high-fat 
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feeding. Bakker and colleagues (Bakker 2009) recently showed that in db/db 
obese mice there is an increase in the size of the perivascular adipocytes of the 
feeding arteries. Adipocytes of bigger size have been shown to produce high 
level of TNF-a (Chatterjee 2009) that could affect the response to insulin at the 
level of feeding and terminal arterioles. Therefore, a paracrine secretion might 
prevent the insulin-mediated microvascular recrnitment without a remarkable 
increase in systemic level. TNF-a infusion was shown impair insulin-mediated 
FBF (Youd 2000). However, this was not the case with the HFD model. This 
would also support a paracrine secretion, as local TNF-a would not be able to act 
on the total blood flow to the leg. 
A recent study has shown that the muscle xanthine oxidase protein levels are 
increased after 10 weeks of high-fat feeding (Erdei 2006). Since the assessment 
of microvascular recrnitment by the 1-MX technique relies on the activity of the 
xanthine oxidase, it was important to verify the activity in the present model. 
Xanthine oxidase activity was identical in both groups. Furthermore, an increase 
in the xanthine oxidase activity would have resulted in a decrease arterial level 
of 1-MX, which is not the case in the 4 week HFD. Another indication of 
preserved activity in the HFD is the level of 1-MX disappearance in the basal 
state. As 1-MX disappearance in the saline infusion groups was not different, it 
is also supportive of similar level of xanthine oxidase activity. Therefore, as the 
level of xanthine oxidase in muscle was not affected by the 4 week HFD, the use 
of the 1-MX technique was justified in these experiments. Explanation for the 
difference in xanthine oxidase activity may relate to the feeding time (10 weeks 
vs. 4 weeks) and/or type of fat composing the diet. Furthermore, 10 week HFD 
fed animals showed an increase in pressure, which was not the case in the 4 
weekHFD. 
Another factor that could have influenced the 1-MX disappearance is a change in 
the capillary density. Although not investigated in the present study, previous 
studies have shown that the capillary density is unchanged following a HFD 
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(Zou 2003, Fueger 2007). Furthermore, as the 1-MX disappearance during the 
saline infusion does not present any change following the HFD, it is unlikely 
that the impairment in microvascular recruitment could be explained by a 
decrease in the number of capillaries. Thus, it is unlikely the insulin-mediated 
capillary recruitment impairment is due to any anatomical change by the dietary 
intervention. 
In summary, insulin-mediated microvascular recruitment is impaired in a pre-
diabetic model of insulin resistance. This finding may be important in linking the 
impairment of nutrient and insulin delivery and the development of insulin 
resistance. It places the defects in vascular action of insulin as an early event in 
the aetiology of type 2 diabetes. By preventing the access of glucose and insulin 
to the myocyte, this may contribute to the myocytes insulin resistance. 
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4.1 INTRODUCTION 
Muscle contraction is another physiological process that regulates glucose 
uptake (Hayashi 1997). The mechanisms by which exercise and insulin increase 
glucose disposal are independent of each other and, interestingly, both are 
additive (Kennedy 1999). Moreover, contraction has been show to increase 
glucose uptake in models of insulin resistance and type 2 diabetes (Wallberg-
Henriksson 1984, Kennedy 1999, Wallis 2002). As exercise has long been the 
cornerstone in the management of diabetes (Weltman 2009), a better 
understanding of the mechanism involved in exercise-mediated glucose disposal 
may lead to improved treatment of this disease. 
For more than a decade studies have shown the physiological importance of 
microvascular recruitment in both insulin- and contraction-mediated glucose 
uptake (Dawson 2002, Rattigan 2005). Microvascular recruitment can be 
measured using different techniques, the most frequently used are the 1-MX 
technique and contrast-enhanced ultrasound (CEU) (Clark 2008). Using these 
techniques it was shown that insulin-mediated microvascular recruitment is 
impaired in type 2 diabetes (Wallis 2002, Clerk 2006, Clerk 2007). However, 
contraction-mediated microvascular recruitment may or may not be impaired in 
type 2 diabetes. In one animal model, the obese Zucker rat, contraction-mediated 
microvascular recruitment responses are preserved as assessed by the 1-MX 
technique (Wheatley 2004). Studies of the microvascular response to exercise in 
humans are not consistent. Experiments using CEU have shown that exercise-
mediated microvascular perfusion is unaffected in type 2 diabetes patients 
(Womack 2009). In contrast, a slight level of impairment of the microvascular 
perfusion during submaximal exercise was observed in type 2 diabetes patients 
using estimated microvascular blood flow kinetics (Qm) (Bauer 2007). It is not 
clear whether the inconsistencies are related to difference in exercise intensity or 
the techniques used to measure microvascular recruitment. Therefore, 
assessment of microvascular recruitment in the same model of insulin resistance 
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using varymg intensities of contraction as well as different techniques to 
measure microvascular recruitment could help explained these inconsistencies. 
The aims of the present study were to assess in a pre-diabetic model of insulin 
resistance: 1) the effect of contraction on muscle glucose uptake and 
microvascular recruitment, 2) directly compare two microvascular recruitment 
measurement techniques (1-MX and CEU) during contraction. 
4.2 MATERIALS AND METHODS 
4.2.1 Animal Care 
Hooded Wistar rats were raised as described in section 2.1. They were divided 
into two groups: one group received the normal diet (ND), while the other group 
received the high-fat diet (HFD). 
4.2.2 In vivo Surgery 
In viva surgery was carried out in anaesthetised rats as described in section 2.2.1. 
For _th_e _contr(lc;tion s_tgdi~s, an incisi9_n \\'_as m_l!de thr9_11gh the skin at the later~l 
side of the hip. Electrodes were attached to the muscle of the hindleg and the 
Achilles tendon (using a curved needle to pierce the skin of the ankle). The foot 
was secured to minimise movement. Twitch stimulation was performed with 0.1 
ms pulses of 30 V current. Animals were subject to contractions at 0.05, 0.1 and 
2 Hz in 15 min stepwise increments. The contralateral leg was used for 
comparison. 
Three different experimental protocols were used to evaluate the effect of HFD 
feeding on muscle contraction (Figure 16, Figure 17 and Figure 19). 
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4.2.2.1 Contraction Protocol #1: Force Development and Glucose 
Uptake 
This protocol was designed to assess the effect of contraction on muscle glucose 
uptake in the HFD fed model (Figure 16). The contractile force developed by the 
soleus, plantaris and gastrocnemius muscle group during each frequency was 
measured by a Harvard Apparatus isometric transducer. The right leg was 
stabilised in a jig with a pin securing the knee to prevent any movement. A 
hooked wire was placed around the Achilles tendon. This hook was attached to 
the isometric transducer, which was interfaced to a computer to allow continuous 
measure of force development via the WINDAQ software program. Voltage 
across the leg was measured using an oscilloscope (Model BWD 506, BWD 
Electronics, Victoria, Australia). 
Glucose uptake following the 2 Hz contraction was measured using the 10 min 
2-DG uptake method (Ross 2007). A bolus of 50 µl 2-deoxy-d-[2,6-3H]glucose 
(1 mCi/ml, Sigma) was injected 10 min before the end of the experiment. 
Immediately after this bolus injection, arterial blood was continuously 
withdrawn at a rate of 50 µl/min over 10 min. This blood sample was used to 
measure the plasma concentrations of 2-DG. At the end of the protocol, the leg 
was rapidly skinned and the calf muscles were freeze-clamped in situ using 
· ·liquid nitrogeff cooled· tongs. After 5 s; the frozen ·calf was excised from· the 
surrounding tissue and placed in liquid nitrogen. Muscle samples were stored at 
-80 °C. Ion-exchange chromatography was used to determine 2-DG uptake, as 
described in section 2.2.3.3. 
Of note, high-fat feeding has previously been shown to increase blood 
coagulation (Olsen 2002). To ensure a continuous arterial withdraw during the 
10 min sampling, a 250 U heparin bolus was arterially injected 5 min prior to the 
arterial withdrawal (Figure 16). Furthermore, frequency of contraction was used 
instead of force of contraction as the later could be altered with voltage, but this 
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changes the amount of contracting fibres that are recruited. By keeping the 
voltage/force constant this variable is removed. 
4.2.2.1.1 High-Energy Intermediates Determination 
High-energy intermediates were extracted from powdered muscle as describe in 
section 2.2.3. 7. All the high-energy phosphates intermediates are expressed as 
µmol/g of wet weight. 
Time • 
2-DG 
Bolus 
50µCi 
@ 
_______,,. 
H • • 
(min) f--t--+--+---+---+---+---+--+--+--+--+--+--+--+--+--+--+--+--+--+---+---+---+--+--+--+---+------1 
-60 -40 -20 0 20 40 
~E_qu_1l_1br_at_1o_n (_te_ns_1o_n _se_t @_10_0_g) __ ~iB_as__,al o 05 Hz 01 Hz 2 Hz 
Exercise st1mulat1on (0 1 msec, 30 volts) 
• Blood sampling (glucose & insulin} 
H Injection of O 05 ml of hepann (250 U) 
@ 2-DG uptake (injection made after 30 min of 2Hz twitch stimulation) 
_______,,. Artenal withdraw at 50 µl/min for 1 O min 
60 80 
Figure 16: ContractiOn protocol#r: Force develojfment and glucose uptake. 
Contraction treatments are indicated by the bars. Bolus injection is shown by @. 
Blood glucose was measured in arterial samples at the times indicated by •. 
Arterial sampling for the determination of radioactivity is indicated by the 
arrow. 
4.2.2.2 Contraction Protocol #2: Capillary Surface Area Perfusion 
The second protocol was designed to measure the effect of contraction on 
perfused capillary surface area in the HFD fed model (Figure 17). 1-MX was 
continuously infused for 60 min, during which a stepwise increase in contraction 
frequency was applied. Femoral artery blood flow in both legs was measured 
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using a Transonic® flow probe positioned around each femoral artery. At the 
completion of the experiment three blood samples were taken, one arterial and 
one venous from each femoral vein. Plasma glucose was measured on each 
sample to allow the calculation ofhindleg glucose uptake, as describe in 2.2.3.2. 
The concentrations of 1-MX, 1-MU and OXY were determined from PCA 
treated plasma samples by HPLC as described in section 2.2.3.5. 
ALP 
Bolus 
~ 
Time 
(mm)l--+--+---+---+---+---+---+---+----i~+--+--+---+--+---+---+---+---+---+-J--+--+---+---+----; • • 
-60 -40 -20 0 20 40 60 
Equ1hbrat1on 1-MX infusion (0.4mg/min/kg) 
005 Hz 01 Hz 2 Hz 
Exercise st1mulat1on (0 1 msec, 30 volts) 
• Blood sampling 
Figure 17: Contraction protocol #2: Capillary surface area perfusion. 
Contraction treatments and 1-MX infusion are indicated by the bars. Bolus 
injection is shown by ~. Blood glucose was measured in arterial samples at the 
times indicated by •. 
4.2.2.3 Contraction Protocol #3: Microvascular Volume 
In the third procedure, contrast-enhanced ultrasound (CEU) was used to assess 
the microvascular volume as describe in section 2.2.3. 7. Linear-array 
transducer/probe (L7-4) was placed on the shaved left leg to allow the imagining 
of the hindleg muscle. Initial trials have determined that the dose curve of 
acoustic intensity as function of micro bubble concentration was identical in both 
diets (Figure 18). 
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Figure 18: Plot of acoustic intensity as a function of microbubble (MB) 
concentration. 
Increasing dilutions of microbubbles were infused at a rate of 45 µl/min into rats 
fed either the ND ( A ) or the HFD ( T ) and the acoustic intensity at a pulsing 
interval of 20 sec recorded. Data are means ± SEM for n = 2-4. 
Animals were electrically stimulated (contraction) for 5 min at each frequency 
before the ultrasound imaging was initiated. Each PI curve required 10 min of 
imaging during contraction. PI curves, AI vs. ultrasound pulsing interval 
(ranging for 0.2-25 seconds) was used to determine the microvascular blood 
volume (A value), microvascular fill rate (p value) and the microvascular blood 
flow (A *P) (see Figure 7). Background subtraction was made by using the 0.5 
sec frames for 0.05 and 0.1 Hz, and 0.2 sec frames for 2 Hz. This enabled the 
assessment of only the microvasculature, as the 0.2/0.5 sec background 
subtraction will remove the signal from larger vessels. 
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Exleg ~ ~ ~ @ basal H z z 
----;;. 
Time • H • • (min) f---+--+--+--+--+--+--+---t-f---+--+--+--+--+--+--+--'~f---+--+--+--+--+--+--+--+--f---+--+--+--+----i 
-60 -40 -20 0 20 40 60 80 
Probe On for equ1ilbrat1on Ma 0.25 ml in 5 ml of saline @ 45µ1/mm 
OOSHz 01Hz 2Hz 
Exercise st1mulat1on (0 1 msec, 30 volts) 
• Blood sampling (glucose & msulm) 
H lniect1on of O 05 ml of heparin (5000U) 
@ 2-DG uptake (miecllon made after 30 mm of 2Hz twitch st1mulat1on) 
_____.,. Arterial withdraw at 50 µI/mm for 1 O min 
Figure 19: Contraction protocol #3: Microvascular volume. 
100 
Contraction treatments and microbubble (MB) infusion are indicated by the bars 
under the timeline. CEU measurements are indicated by the boxes on top of the 
timeline. Bolus injection is shown by @. Blood glucose was measured from 
arterial samples at the times indicated by •. Arterial sampling for the 
determination of radioactivity is indicated by the arrow. 
4.2.3 Data Analysis 
All data are expressed as means ± SEM. Data were calculated as described in 
section 2.2.4. Comparisons hetween basal value for e-ach- diet, and differences 
between basal and final values were assessed using a paired t-test, unless stated 
otherwise in the figure legend. Comparisons were made between treatment 
groups over the course of the experiment using two-way repeated-measures 
ANOVA with Student-Newman-Keuls post hoe test as mentioned in the 
corresponding figure legend. All tests were performed using the SigmaStat 
statistical program (Systat Software Inc, CA, USA). 
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4.3 RESULTS 
4.3.1 Characteristics of the High-Fat Diet Fed Rats 
Table 3 summarises the difference between the ND and the HFD fed subgroups 
for body weight, epididymal fat pad weight, and plasma glucose and insulin. 
Duplicate plasma measurements were taken at the end of the contraction period. 
As seen in chapter 3, HFD rats developed a pre-diabetic state of insulin 
resistance. HFD feeding resulted in increase body weight, larger epididymal fat 
pads, higher plasma glucose and plasma insulin in compared with the ND. 
Following contraction, the ND rats had a significant increase in plasma glucose 
(Fasting = 5.22 ± 0.13 mmol/l vs. Endpoint = 5.75 ± 0.16 mmol/l, p<0.05) 
(Table 3). This can be explained by feed-forward regulation of hepatic glucose 
production occurring during exercise (Sonne 1985, Suh 2007). Interestingly, this 
hepatic feed-forward mechanism was absent in the HFD groups, where there 
was no significant difference in plasma glucose before and after contraction. 
72 
CHAPTER4: 
CONTRACTION-MEDIATED EFFECTS ON MICROVASCULAR 
RECRUITMENT IN THE PRE-DIABETIC STATE 
Table 3: Characteristics of rats fed normal diet or high-fat diet for 4 weeks 
used for the contraction protocols. 
Body weight (g) 
Epididymal fat pad (g) 
Fasting plasma glucose (mmol/l) 
Normal Diet 
235 ±2 
1.05 ± 0.04 
5.22 ± 0.13 
High-Fat Diet 
243 ± 3 * 
2.15±0.15 ** 
6.27 ± 0.14 ** 
Fasting plasma insulin (pmol/l) 61±7 154 ± 18 ** 
·-------------------------------------------------------------------------------------------------------
Endpoint (2Hz) plasma glucose 
(mmol/l) 
Endpoint (2Hz) plasma insulin 
(pmol/l) 
5.75 ± 0.16 # 
83±10 
6.45 ± 0.17 ** 
180±18** 
Data are means ± SE for n = 18-23 rats in each group. * p<0.05 and ** p<0.01 
vs. ND, # p<0.05 vs. fasting level, paired student t-test. Epididymal fat pads 
were removed from rats at the completion of each experiment. 
4.3.2 Contraction Protocol #1: Force Development and Glucose Uptake 
4.3.2.1 Evaluation of the Contraction in the HFD 
The voltage during the electrical stimulation was measured across the 
contracting leg (Figure 20A) and was identical in both treatment groups (ND= 
7.7 ± 0.3 volts vs. HFD = 7.7 ± 0.9 volts, p<0.05). The force of the contraction 
during the field stimulation was also similar in both ND and HFD rats (Figure 
20B). During the 2 Hz contraction, a two-phase force development occurred 
where the first 5 min was characterised by a sharp increase in force development 
followed by a slow decrease overtime (Figure 20B). 
4.3.2.2 Hemodynamic Measurements 
Mean arterial pressure was similar between ND and HFD fed groups (Figure 
21A). An increase in MAP occurred after 2 Hz contraction, but did not reach 
significance. MAP for the last 10 min could not be obtained due to the arterial 
withdraws needed for the detennination of 2-DG uptake. Heart rate increased 
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after 10 min of 2Hz contraction and this effect was similar in both treatment 
groups (Figure 21B). 
4.3.2.3 Skeletal Muscle Glucose Metabolism 
The basal level of the calf muscle glucose uptake, as seen in the resting leg, was 
unchanged with HFD (ND= 3.6 ± 0.1 µg/g/min vs. HFD = 3.8 ± 0.3 µg/g/min, 
NS) (Figure 22). The glucose uptake induced by contraction increased by 11 fold 
and this effect was similar in both groups (ND= 42.7 ± 4.3 µg/g/min vs. HFD = 
43.7 ± 4.3 µg/g/min, NS). 
4.3.2.4 High-Energy Intermediates 
Table 4 shows that calf muscles isolated from the HFD rats have an increased 
ratio of dry weight/wet weight (ND= 0.201 ± 0.004 vs. HFD = 0.217 ± 0.006, 
p<0.05). This is a consequence of an increase in dry weight, due to an increase 
accumulation of intramuscular triglycerides (Kraegen 1991 ). However, beside a 
small decrease in ADP content of the HFD calf muscle, there were no 
differences in high-energy phosphates (Table 4). 
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Figure 20: Contraction protocol #1: Voltage and force development during 
leg contraction. 
Electrical stimulation-mediated (A) voltage and (B) force development in lower 
leg muscles of test leg in rats fed a ND( .& ) or HFD ( T ) for 4 weeks. Voltage 
across the leg was measured using an oscilloscope and force was detennined by 
an isometric force transducer attached to the Achilles tendon. Data are means ± 
SEM for n = 8. # p<0.05 from contraction at 0.05 Hz, using two-way RM 
ANOV A with post-hoe analysis using SNK method. 
75 
A 
-C'I 
:::c 
E 
.§. 
0.. 
< ~ 
B 
SE' 
0.. 
m 
-a:: 
:::c 
CHAPTER4: 
CONTRACTION-MEDIATED EFFECTS ON MICROVASCULAR 
RECRUITMENT IN THE PRE-DIABETIC STATE 
Mean Arterial Pressure 
140 
120 
100 
80 
60 
40 
20 
0 0.05 Hz 0.1 Hz 2 Hz 
0 10 20 30 40 50 60 70 
Time (min) 
Heart Rate 
500 
# for both diets 
400 
300 
200 
100 
0 0.05 Hz 
0.1 Hz 2 Hz 
0 10 20 30 40 50 60 70 
Time (min) 
Figure 21: Contraction protocol #1: Mean arterial pressure and heart rate. 
Time course for mean arterial pressure (A) and heart rate (B) as a result of 
electrical stimulation in rats fed a ND ( • )or HFD ( T ) for 4 weeks. Data are 
means± SEM for n = 8. # p<0.05 from basal, using two-way RM ANOV A with 
post-hoe analysis using SNK method. Last 10 min of MAP could not be 
obtained due to the arterial withdraws needed for the 2-DG uptake measurement. 
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Figure 22: Contraction protocol #1: Calf muscle 2-DG uptake. 
Muscle radioactive 2-DG uptake (R'g) for both resting and contracting legs as a 
result of electrical stimulation in rats fed a ND (•) or HFD (• ) for 4 weeks. 2-
DG was administered as a bolus after 30 min of 2 Hz contraction (Figure 16) and 
calf muscles were excised 10 min later. Data are means ± SEM for n = 8. * 
p<0.05 from resting leg of same diets, using two-way RM ANOV A with post-
hoc analysis using SNK method. 
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Table 4: Contraction protocol #1: High-energy intermediates content of calf 
muscles after 2 Hz contraction. 
Normal Diet High-Fat Diet 
Dry wt/Wet wt 0.201 ± 0.004 0.217 ± 0.006 * 
Creatine (µmol/g wet weight) 18.93 ± 0.88 17.96 ± 0.88 
Phospho-Creatine (µmol/g wet weight) 23.99 ± 0.52 22.84 ± 0.87 
PCr/Cr 1.28 ± 0.05 1.28 ± 0.05 
ATP (µmol/g wet weight) 6.41±0.14 5.95 ± 0.32 
ADP (µmol/g wet weight) 0.53 ± 0.03 0.44 ± 0.02 * 
AMP (µmol/g wet weight) 0.069 ± 0.006 0.065 ± 0.005 
NAD (µmol/g wet weight) 0.66 ± 0.03 0.61±0.03 
Energy Charge 0.952 ± 0.002 0.955 ± 0.002 
Data are means ± SEM for n = 8 rats in each group. * p<0.05, vs. ND, paired 
student t-test. Calf muscles were freeze clamped then removed from rats at the 
completion of each experiment. 
78 
CHAPTER4: 
CONTRACTION-MEDIATED EFFECTS ON MICROVASCULAR 
RECRUITMENT IN THE PRE-DIABETIC STATE 
4.3.3 Contraction Protocol #2: Microvascular Recruitment 
4.3.3. J Hemodynamic Measurements 
Mean arterial pressure was similar between ND and HFD fed groups (Figure 
23A). A significant increase in MAP occurred after 5 min of 2 Hz contraction, 
however MAP for the last 10 min could not be obtained due to the arterial 
withdraws needed for the determination of 2-DG uptake. Heart rate was similar 
in both group and was not affected by the contractions (Figure 23B). 
4.3.3.2 Femoral Blood Flow 
FBF showed a similar response to contraction in both ND and HFD fed groups. 
FBF significantly increased 15 min after 0.1 Hz frequency and throughout the 2 
Hz contraction (Figure 24A). There was a 2.5 fold increase in the FBF of the 
contracting leg after 5 min of 2 Hz, with no difference in the amplitude of the 
increase between treatment groups (ND= 2.71 ± 0.19 ml/min vs. HFD = 2.52 ± 
0.15 ml/min, NS). Although there was a trend for a decrease in FBF in the non-
contracted leg during the contraction of the contralateral leg, this was not 
significant (Figure 24B). 
4.3.3.3 1-.MX M£tabolism _Assessme_nt of the Perfused _Ca]lillary Surface 
Area 
Increase in perfused capillary surface area, a marker of microvascular 
recruitment, was unaffected by the diets (ND= 9.61 ± 0.99 nmol/min vs. HFD = 
11.20 ± 1.60 nmol/min, NS) (Figure 25A). Of note, the microvascular 
recruitment observed in the resting leg was also unaffected by the dietary 
modification (ND = 4.13 ± 0.59 nmol/min vs. HFD = 4.97 ± 1.01 mnol/min, 
NS), indicative of similar basal level of capillary surface area perfusion in both 
groups. 
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4.3.3.4 Skeletal Muscle Glucose Metabolism 
Basal level of muscle glucose uptake, as seen in the resting leg, was unchanged 
with HFD (ND = 0.06 ± 0.03 µmol/min vs. HFD = 0.03 ± 0.03 µmol/min, NS). 
Electrical stimulation increased HGU to a similar extend in both groups (ND= 
0.75 ± 0.08 µmol/min vs. HFD = 0.74 ± 0.10 µmol/min, NS), representing a ~12 
fold increase from resting levels, consistent with the 2-DG uptake in contraction 
protocol #1. 
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Figure 23: Contraction protocol #2: Mean arterial pressure and heart rate. 
Time course for mean arterial pressure (A) and heart rate (B) as a result of 
electrical stimulation in rats fed a ND ( • ) or HFD ( 'Y ) for 4 weeks. Data are 
means ± SEM for n = 5-6. # p<0.05 from basal, using two-way RM A OVA 
with post-hoe analysis using SNK method. 
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Figure 24: Contraction protocol #2: Femoral blood flow in contracting and 
resting leg. 
Time course for the femoral blood flow for both contracting (A) and resting (B) 
legs as a result of electrical stimulation in rats fed a ND (A) or HFD ( T ) for 4 
weeks. Data are means ± SEM for n = 5-6. # p<0.05 from basal, using two-way 
RM ANOV A with post-hoe analysis using SNK method. 
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Figure 25: Contraction protocol #2: Capillary surface area perfused and 
hindleg glucose uptake. 
Hindleg glucose uptake measurements (A) and 1-MX metabolism (B) as a result 
of 2 Hz electrical stimulation in rats fed a ND (•) or HFD (• ) for 4 weeks. 
Hindleg glucose uptake was measured by the blood glucose arterio-venous 
difference multiplied by the femoral blood flow. Data are means ± SEM for n = 
5-6. * p<0.05 from resting leg of same diets, using two-way RM ANOV A with 
post-hoe analysis using SNK method. 
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4.3.4 Contraction Protocol #3: Microvascular Volume 
4.3.4.1 Hemodynamic Measurements 
As seen in Figure 26, MAP and HR were similar between diets, and remained 
unchanged at 0.05 and 0.1 Hz contractions. During the 2 Hz contraction, an 
increase in MAP and HR occurred, with significantly greater increase in the 
HFD compared to the ND (Figure 26A). 
4.3.4.2 CEU Assessment of the Microvascular Volume 
Microvascular blood volume (MBV) significantly increased from resting level 
during 2 Hz contraction for both diets, and at 0.1 Hz in ND (Figure 27 A). 
Although it did not reach significance, the increase in MBV during 2 Hz 
contraction was smaller in the HFD rats compared to the ND level (ND = 22.5 ± 
4.5 AI vs. HFD = 15.3 ± 2.6 AI, p=0.07). Furthermore, microvascular flow rate 
(MFR) and microvascular blood flow (MBF) showed similar pattern with each 
diet, where 0.05 and 0.1 Hz contractions did not have an effect on either MFR 
(Figure 27B) or MBF (Figure 27C). On the other hand, 2 Hz contraction induced 
a significant increase in MFR and MBF, which was significantly less in the HFD 
fed animals. 
4.3.4.3 Skeletal Muscle Glucose Metabolism 
Basal level of muscle glucose uptake, as seen in the resting leg, was unchanged 
with HFD (ND = 2.0 ± 0.2 µg/g/min vs. HFD = 2.32 ± 0.2 µg/g/min, NS) 
(Figure 28). The glucose uptake induced by contraction increased significantly 
during 2 Hz contraction, and levels were similar in both groups (ND= 43 ± 13 
µg/g/min vs. HFD = 27 ± 12 µg/g/min, NS). 
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Figure 26: Contraction protocol #3: Mean arterial pressure and heart rate. 
Time course for mean arterial pressure (A) and heart rate (B) as a result of 
electrical stimulation in rats fed a ND (A) or HFD ( "Y ) for 4 weeks. Data are 
means± SEM for n = 9. # p<0.05 from Basal, * p<0.05 from ND, using two-way 
RM ANOV A with post-hoe analysis using SNK method. 
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Figure 27: Contraction protocol #3: CEU imaging of the microvascular 
space. 
Effects of different frequencies of electrical stimulation on microvascular blood 
volume (A), flow rate (B) and blood flow (C) in rats fed a ND (•)or HFD (• ) 
for 4 weeks. Measurements were made by contrast enhanced ultrasound using 
phospholipid microbubbles before c01mnencement of contraction (Basal) and 
after 5 min of contraction at each frequency. Data are means± SEM for n = 9. # 
p<0.05 from Basal, * p<0.05 from ND of same frequency, using two-way RM 
ANOV A with post-hoe analysis using SNK method. 
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Figure 28: Contraction protocol #3: Muscle glucose uptake. 
Muscle radioactive 2-DG uptake (R'g) for both resting and contracting legs as a 
result of electrical stimulation in rats fed a ND (•) or HFD (• ) for 4 weeks. 2-
DG was administered as a bolus after 30 min of 2 Hz contraction (Figure 19) and 
calf muscles were excised 10 min later. Data are means ± SEM for n = 5-6. # 
p<0.05 from Basal, * p<0.05 from ND of same frequency, using two-way RM 
ANOV A with post-hoe analysis using SNK method. 
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4.4 DISCUSSION 
Two main findings resulted from the present study. The first finding was that 
metabolic responses to contraction after 4 weeks HFD fed rat was preserved in 
the skeletal muscle. Electrical stimulations induced similar force development, 
high-energy intermediates profile, and glucose uptake regardless of the diets. 
This data is consistent with contraction experiments in the obese Zucker rat 
(Wheatley 2004) showing essentially normal contraction-mediated glucose 
uptake response in this model of type 2 diabetes. 
Measurements of skeletal muscle glucose uptake were made using different 
techniques (R'g and HGU) and after different periods of 2 Hz contraction (15 
min and 40 min). In all these procedures, contraction elicited similar muscle 
glucose uptake in both the ND and HFD groups. This was important to verify as 
controversy exist in the literature as to whether contraction-mediated glucose 
disposal is impaired after a HFD. Several reports found exercise-mediated 
glucose uptake to be normal following an HFD (Kusunoki 1993, Liu 1996), 
while others showed a decrease (Rosholt 1994, Han 1997, Hansen 1998, Tanaka 
2007). The reason for this inconsistency may reside in experimental procedure. 
Studies where the exercise-mediated glucose uptake was assessed in viva 
reported no effect of the HFD on glucose disposal. On the other hand, decreases 
in glucose uptake were -observed after an HFD when the glucose uptake was -
assess using the incubated muscle preparation. As this procedure required 
excision of the muscle after exercise, this technique may not be indicative of the 
glucose uptake occurring during exercise, but instead represent the glucose 
uptake post-exercise. Furthennore, the contribution of the microvasculature is 
non-existent in the incubated muscle preparation. As the microvascular 
component has been shown to be crucial for glucose uptake, this component 
should be considered when studying muscle glucose uptake. 
Intramyocellular lipids (IMCL) have been shown to be increased after a HFD 
(Tanaka 2007). Although not assessed directly in the present study, the increase 
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in dry weight/wet weight ratio would support an increase in IMCL in the present 
model (Table 4). As the putative physiological function of IMCL is to serve as 
an energy source for muscular fatty acid oxidation (Krssak 2000, Schrauwen-
Hinderling 2006), increases in IMCL content in the HFD could have modified 
the fuel usage during contraction. However, similar high-energy intermediates 
profiles and glucose uptake after contraction found in the present study indicates 
that the metabolic usage of the contracting muscle was similar in both diets. This 
is consistent with a study showing that consumption of a high-fat diet for one 
week is accompanied by molecular changes favouring fat storage in skeletal 
muscle rather than oxidation (Schrauwen-Hinderling 2005). 
The second significant finding from the present study was that different 
techniques of assessment of the microvascular recruitment resulted in discordant 
results. 1-MX assessment of the microvascular recruitment showed no difference 
between ND and HFD. Both have similar level of 1-MX metabolism during 
contraction (ND = 9.61 ± 0.99 nmol/min vs. HFD = 11.20 ± 1.60 nmol/min, 
NS). However, CEU assessment of the microvascular volume showed an 
impairment of the contraction-mediated microvascular recruitment. Indeed, 
microvascular blood volume (p=0.07), microvascular flow rate and 
microvascular blood flow were all blunted in the HFD fed animal during the 2 
Hz contn!ction (Figllre 27). This_ w~s surprising, _as 1-MX and CEU as_sessment 
of microvascular recruitment have always yielded similar outcomes in the past 
(Dawson 2002, Clark 2008). It is also the first time that CEU was used to assess 
contraction-mediated microvascular recruitment in a model of insulin resistance. 
Studies in humans with CEU have showed that type 2 diabetes patients without 
microvascular complication have preserved exercise-mediated microvascular 
recruitment (Womack 2009). However, in type 2 diabetic patients having other 
microvascular complications (defined by a proteinuria or a diagnosis of 
neuropathy), exercise-mediated microvascular recruitment was decreased. 4 
weeks HFD is unlikely to have induced these other microvascular complications, 
which only become apparent in later stage of type 2 diabetes. Future experiments 
are needed to assess contraction-mediated microvascular recruitment with CEU 
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in the obese Zucker rats. Microvascular recruitment was previously assessed in 
this model by the 1-MX technique and was shown to respond normally to 
contraction (Wheatley 2004), therefore it would be interesting to verify if the 
CEU technique of assessing the microvascular recruitment during contraction 
reproduces the results observed in the HFD model. 
The metabolic effects of contraction and force development in the current study 
were not affected by HFD, indicative of a preserved response of the 
microvasculature to contraction. Therefore, assessment of the microvascular 
recruitment during contraction with 1-MX is a more reliable method than CEU. 
Indeed, decreases in delivery of blood during exercise would have affected the 
muscle contraction, glucose uptake, and high-energy intermediates. Thus, 
difference between the two techniques for measuring microvascular recruitment 
may account for the observed decrease in microvascular volume in the HFD. 
Results from the current study have demonstrated that measurements of 
microvascular recruitment using 1-MX and CEU techniques provide different 
information about microvascular recruitment, which could be responsible for the 
inconstancy of the results. 1-MX metabolism is a biochemical measure that 
relies on the presence of xanthine oxidase at the surface of capillaries and thus 
the values of 1-MX metabolism reflect the perfused capillary surface area. As 
describe in section 2.2.3.5, 1-MX technique utilises the infusion of a soluble 
molecule (1-methylxanthine) to assess microvascular recruitment. On the other 
hand, CEU utilises a contrast agent consisting of gas filed lipid-shell 
microbubbles to obtain an image of the perfused microvascular space. 
Measurements obtained from this technique reflect microvascular red blood cells 
volume (see section 2.2.3.7). Therefore, a difference in the access of the 1-MX 
and the microbubbles to the microvasculature could explain the inconsistencies 
in the present study. One factor that could affect the access of the micro bubbles 
is an increased presence of the glycocalyx on the capillaries surface after 4 
weeks HFD (Reitsma 2007). 1-MX may diffuse freely through the glycocalyx to 
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reach the xanthine oxidase at the surface of the vessels while the increase in the 
thickness of the glycocalyx could limit the accessibility of the microbubbles to 
the microvascular space. This could explain the decrease in volume seen in 
Figure 27 A. Since total blood flow was not significantly different between diets, 
a decrease in microvascular blood volume would perhaps be expected to be 
matched by a increase in the microvascular flow rate. The CEU measurements 
indicated that no increase in microvascular flow rate was associated with the 
decreased microvascular volume. However, as has been observed previously, 
total blood flow and microvascular blood flow do not always correlate as blood 
flow can be redistributed between high flow non-nutritive routes and nutritive 
routes (Rattigan 1997, Zhang 2004). Therefore, an exclusion of the 
microbubbles from the microvasculature (by an increase in glycocalyx or other) 
combined with blood flow going to the high-flow non-nutritive vessels, 
undetectable by CEU, may explain the unexpected findings using this technique. 
However, it should be mentioned that glycocalyx have been shown to be 
decreased during experimental hyperglycaemia (Nieuwdorp 2006) and type 1 
diabetes (Nieuwdorp 2006). Glycocalyx levels of the microvasculature have not 
been assess after an HFD and may have been affected differently in this model. 
However, the glycocalyx level will need to be directly assess in the HFD model 
before any definitive conclusion can be drawn. 
Another possible explanation for differences in CEU findings may lie in the 
spatial resolution of CEU. Indeed, tens to hundreds of capillaries can be in a 
single pixel area, therefore changes in signal within a pixel may be not be 
properly detected. Furthermore, CEU technique cannot discriminate between 
different flow patterns within muscle (Ross 2008), and the present data may 
have been affected by changes in the non-nutritive route. 
In conclusion, contraction-mediated metabolic and FBF response are preserved 
in a pre-diabetic state of insulin resistance. As contraction-mediated glucose 
disposal is preserved after a 4 weeks HFD, even though the insulin-mediated 
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response is impaired, it supports the hypothesis of different mechanisms for 
insulin and contraction effects. On the other hand, conflicting data were obtained 
with the measurement of microvascular recruitment, where 1-MX assessment of 
the microvascular recruitment was intact while the CEU showed an impairment. 
As glucose uptake was unchanged after HFD feeding, this would indicate that 
capillary surface area is more impotiant for the disposal of glucose than the 
microvascular volume. Further experiments in models of insulin resistance and 
type 2 diabetes need to be done to confirm these results, as it would cast doubt 
on the effectiveness of measuring microvascular recruitment with CEU during 
contraction. On the other hand if confirmed then it would indicate that the HFD 
has subtly altered the microvasculature that affects microvascular volume but 
not surface area changes during contraction. 
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5.1 INTRODUCTION 
The diabetic state is characterised by a lack of insulin action in different organs, 
including the liver (Kraegen 1991, Bergman 2001), the adipose tissue (Bergman 
2001) and the skeletal muscle (Crettaz 1981, Baron 1991, Krook 2000). 
Decreased insulin action has been observed in skeletal muscle during the initial 
stage of insulin resistance (Rothman 1995) and before the appearance of systemic 
insulin resistance (Kraegen 1991). Furthermore, improvements to skeletal muscle 
insulin sensitivity either by exercise training (Schneider 1984, Ivy 1997, 
Goodyear 1998, Pauli 2008) or by drug intervention (Hallsten 2002, Meyer 2002) 
enhance systemic insulin sensitivity, demonstrating the importance of the skeletal 
muscle in the pathogenesis of type 2 diabetes. 
Endothelial dysfunction is defined as a state where there is a decrease in the NO 
mediated vasodilatation (Vanhoutte 2009), primarily of the resistance arterioles. 
Associated with this dysfunction is an impairment of the insulin-mediated 
increase in blood flow and glucose disposal in skeletal muscles (Baron 1997). 
Thus, endothelial dysfunction has also been implicated in the insulin resistant 
state, where it could lead to a decrease in insulin-mediated glucose uptake (Kim 
2006, Jansson 2007). 
In viva studies in anaesthetised rats showed that the muscle microvasculature, and 
its response to insulin stimulation, is essential for optimal insulin-mediated 
glucose uptake. As shown in chapter 3 of the present thesis, insulin-mediated 
microvascular recruitment is inhibited in the early stage of insulin resistance and 
is accompanied by a ~40 % decrease in insulin-mediated glucose uptake. 
Furthermore, pharmacological treatments using infusions of TNF-a (Youd 2000), 
a-methylserotonin (Rattigan 1999) or intralipids (Clerk 2002) results in the 
prevention of insulin-mediated microvascular recruitment and approximately 50 
% decrease in insulin-mediated skeletal muscle glucose uptake. Thus, all of these 
treatments lead to an acute vascular state of insulin resistance by limiting insulin 
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and glucose access to skeletal muscle. These studies confirm the importance of 
the microvasculature in glycaemic control as insulin-mediated glucose uptake is 
impaired by the lack of insulin's vascular actions. While these pharmacological 
treatments support the idea that muscle microcirculation is involved in insulin-
mediated glucose uptake, they do not rule out the effect of other tissues. Indeed, 
infusions of TNF-a, a-methylserotonin and intralipids were conducted 
systemically, therefore the effects of the liver and the adipose tissue cannot be 
ruled out. 
Additional evidence of a role for microvasculature in insulin-mediated glucose 
uptake came from isolated hindleg perfusion experiments. Using this preparation, 
partial occlusion of the rat hindlimb vasculature (with 15µm diameter latex 
microspheres (MS)) was shown to impair insulin-mediated activation of Akt and 
decrease glucose uptake by 46% (Vollus 2007). This study provided evidence that 
a decrease in the delivery of insulin to the myocytes is sufficient to prevent the 
insulin-mediated glucose uptake in situ. The MS occlusion is a more 
advantageous approach than pharmacological treatments, as physical occlusion 
directly limits the perfusion to the muscle while pharmacological treatments may 
have other cells and tissues effects. 
The aim of the present study was to evaluate the involvement of microvascular 
delivery in insulin-mediated skeletal muscle glucose uptake in vivo. The 
hypothesis was that prevention of insulin-mediated microvascular recruitment 
would decrease the insulin-mediated glucose disposal. Therefore, insulin-
mediated glucose uptake was studied in the isoglycaemic hyperinsulinaemic 
clamp following partial occlusion of the microvascular beds with 15µm diameter 
latex MS. 
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5.2 MATERIAL AND METHODS 
5.2.1 Animal Care 
Hooded Wistar rats weighing 2S2 ± 2 grams were used during this experiment. 
The rats were raised as described in section 2.1. Rats were not fasted prior to the 
experiments, as the determination of whole body glucose kinetics was not 
required. 
5.2.2 Surgery 
Experiments were conducted using the anaesthetised rat model, with surgery as 
described in section 2.2.1. 
5.2.3 Epigastric Cannulation for Microsphere Injection 
After careful separation of the epigastric vessels from the overlying connective 
tissue, an incision was made in the epigastric artery using an insulin syringe 
needle. The artery was then cannulated using a homemade cannula comprising a 
blunted 27G needle (Terumo, Tokyo, Japan) connected to PESO size tubing 
(Microtube Extrusions, NSW, Australia). A successful cannulation resulted in 
arterial blood pulsing into the tubing. Once the cannula was firmly secured with 
7-0 size silk tie, flow probes were positioned on the femoral arteries of both legs 
as previously described. Prior to the MS injection, LDF probe (Laser Doppler 
Perfusion Monitor moorLAB server, Moor Instruments, USA) was positioned on 
the sole of the cannulated foot. The LDF probe was used to assess the blood flow 
going through the foot. A haemostatic clamp, applied at the Achilles region, was 
used to restrict blood flow to the large shunt vessels of the foot. A injection of 
2SO µl of the MS mix (or saline in sham experiments) comprising a 
predetermined amount of MS (Fluka, Germany) and S0,000 fluorescent MS 
(Molecular Probe, USA) was then injected retrogradely via the epigastric artery 
over a period of 10 sec. This was immediately followed by flushing the cannula 
with 200 µl of saline. The entire injection procedure lasted about 90 sec. 
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Following the injection, both epigastric vessels were ligated and the animal was 
left to equilibrate for I-hour before commencmg the isoglycaemic 
hyperinsulinaemic clamp. In addition to sham treated rats, the contralateral leg in 
each experiment was used to compare the effects of occlusion within each group. 
The stock solution of MS was counted on a haemocytometer at regular intervals 
to ensure than the same amount of MS was injected in each procedure. 
Femorol 
artery 
Ctrlleg I Treated leg I 
Epigastric artery 
cannulated 
Figure 29: Epigastric Cannulation for Microsphere Injection 
Surgery details are given in section 5.2.3. Briefly, the epigatric artery of one leg 
(Treated leg) was cannulated using a homemade camrnla to enable the local 
injection of either a mix of microsphere or a bolus of saline. The contralateral leg 
in each experiment (Ctrl leg) was used to compare the effects of occlusion within 
each group. Diagram adapted from Mahajan et al. (Mahajan 2004). 
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5.2.4 Experimental Procedure 
The local effects of MS occlusion on the skeletal muscle microvasculature were 
assessed during an isoglycaemic hyperinsulinaemic clamp as described in section 
2.2.2. Briefly, 1-hour after the injection of the MS/saline bolus into the epigastric 
artery on the treated leg, saline or insulin (10 mU/min/kg) was initiated and 
continued for 2 hours (Figure 6). During experiments involving insulin infusion, a 
glucose solution (30 % w/v) was also infused at variable rates to maintain blood 
glucose levels around at basal. Femoral artery blood flow was continuously. 
measured using Transonic® flow probes positioned around the femoral arteries of 
both legs. The 1-MX disappearance was used as an indicator of perfused capillary 
surface area as described in section 2.2.3.5. A bolus dose of [3H] 2-DG (50 µCi) 
was given 45 min before the end of the experiment. Calf muscles were excised at 
the completion of the experiment and freeze clamped in liquid nitrogen to assess 
the 2-DG uptake as described in section 2.2.3.3. Selected tissues (tibialis anterior, 
lung, heart, quadrate lobe of the liver) were excised from rats and kept at -20 °C 
until the fluorescence could be assessed. 
5.2.4.1 High-Energy Intermediates Determination 
Calf muscles were ground under liquid nitrogen and used to assess the high-
energy intermediate content. Extraction and measurement techniques are 
described in section 2.2.3.7. 
5.2.4.2 Fluorescence 
All tissue samples were weighed in 50 ml centrifuge tubes and digested using 
previously published methods (Rattigan 1997). Each tissue was incubated in a 
volume of 10 ml of tissue solubilising solution (2 M KOH in 95 % ethanol with 
0.5 % Tween 80) per gram of tissue. Tubes were left overnight at room 
temperature to allow dissolving, after which the supernatant was discarded 
following 20 min centrifugation at 2500 RPM (Damon/IEC). The formed pellet 
was resuspended in 15 ml of water. After another centrifugation (20 min at 2500 
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RPM), the supernatant was again removed (leaving 0.5 ml on pellet) before 
adding 5 ml of 2-epoxy ethylacetate (MS dissolving solvent). Over the course of 
an hour, the solution was vortexed several times to ensure the complete 
dissolution of the fluorescent MS. The dissolving solution was then centrifuged at 
2500 RPM for 20 min. The fluorescence intensity of the supernatant was 
determined by spectrophotofluorometry (Aminco-Bowan, USA) at an excitation 
wavelength of505 nm and an emission wavelength of 515 nm. 
For each experiment, fluorescence intensity of 10 µl of the MS mix injected in 
each animal (dissolved in 5 ml of 2-epoxy ethylacetate) was assessed. This 
allowed the expression of tissue fluorescence as a percentage of the total injected 
fluorescence. 
5.2.5 Data Analysis 
All data are expressed as means ± SEM. Data were calculated as described in 
section 2.2.4. The effect of different doses MS on high-energy intermediates was 
assessed with one-way ANOVA with post-hoe analysis using Bonferroni's 
method to compare with the sham (0 MS) treated group. Comparisons were made 
between treatment groups over the course of the experiment using two-way non-
repeated or repeated-measures ANOVA with Student-Newman-Keuls post hoe 
test as indicated in the figure legends. All tests were performed using the 
SigmaStat statistical program (Systat Software Inc, CA, USA). 
5.3 RESULTS 
5.3.1 Tissue Localisation of MS 
Initial studies were made to assess the tissue distribution of the injected MS. 
These studies showed that after a retrograde epigastric arterial injection, less than 
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10 % of the MS were located within the lower leg muscles and 44 % were located 
in the lung. In subsequent studies, the blood flow to the large shunt vessels in the 
feet was restricted before and during MS injection by clamping the ankle region 
with a haemostatic clamp to ensure a redirection of the MS into the lower leg 
muscles. Following this procedure, 84 % of the locally injected fluorescent MS 
were recovered in the treated leg, 18 % of which were within the calf muscles 
(soleus, EDL, red and white gastrocnemius). Meanwhile, fluorescence in the 
tibialis anterior accounted for approximately 4 % of the injected MS. 
5.3.2 Determination of the MS Dose Required for the Occlusion of the 
Muscle Microvasculature 
Initial trials were conducted to determine the number of MS that were required to 
impair the microvascular delivery to skeletal muscle. This was assessed by 
measuring the calf muscles high-energy intermediates content after an injection of 
0, 1.5, 3 or 7 x106 MS. Two parameters were closely monitored: the PCr/Cr ratio 
(a marker of adequate microvascular blood delivery) and the energy charge (EC) 
(a marker of cellular damage). As seen in Table 5, 1.5 x106 MS did not affect the 
PCr/Cr ratio or the EC. 3 x106 MS induced a decrease in PCr/Cr ratio without 
affecting the EC while 7 x106 MS induced a decrease in both PCr/Cr ratio and 
EC. Therefore, only 3 x106 MS impaired the microvascular delivery of blood 
without inducing cellular damage. 
During these initial trials, insulin-mediated microvascular recruitment was also 
assessed to determine the appropriate dose of MS to impair this process. As seen 
in Figure 30, 1.5 x106 MS did not significantly affect the insulin-mediated 
microvascular recruitment. In contrast, a significant impairment occurred at the 
higher doses of 3 and 7 x106 MS. 
The 3 x106 MS dose was the only one that decreased the PCr/Cr ratio and 
prevented insulin-mediated microvascular recruitment without affecting the EC. 
100 
CHAPTERS: 
ACUTE MICROSPHERE OCCLUSION INDUCED VASCULAR INSULIN 
RESISTANCE 
Prior studies using the perfused hindlimb (Vollus 2007) also indicated that 3 x 106 
MS prevented the insulin-mediated glucose uptake. As a result, an injection of 3 
x 106 MS was judged to represent the most suitable dose of MS for the partial 
occlusion of the microvasculature. Therefore, this dose was used in subsequent 
experiments to determine the effect of MS occlusion on the insulin-mediated 
glucose uptake during an isoglycaemic hyperinsulinaemic clamp in viva. It should 
be noted that incorrect values were provided for the dose of MS used in the 
hindlimb perfusion paper (Vollus 2007). The MS doses of 9, 15 and 30 x106 MS 
should have been labelled 1.5, 3 and 7 x106 MS (personal communication with S. 
Rattigan). 
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Table 5: Effects of different doses of MS on high-energy intermediates of the 
calf muscle group. 
Microspheres 
(x106) 
Dry wt/Wet wt 
Crea tine 
(µmol/g dry weight) 
Phospho-
Crea tine 
(µmol/g dry weight) 
PCr/Cr 
ATP 
(µmol/g dry weight) 
ADP 
(µmol/g dry weight) 
AMP 
(µmol/g dry weight) 
NAD 
(µmol/g dry weight) 
Energy Charge 
0 
0.212 ± 0.004 
86± 5 
124±3 
1.46 ± 0.09 
30.96 ± 0.65 
3.33 ± 0.32 
0.24± 0.04 
3.01±0.11 
0.945 ± 0.005 
1.5 
0.223 ± 0.005 
68 ± 11 
84± 8 
1.33 ± 0.15 
24.45 ± 2.86 
1.75 ± 0.16* 
0.35 ± 0.09 
2.55 ± 0.26 
0.954 ± 0.001 
3 7 
0.192 ± 0.010 0.178 ± 0.007* 
100 ± 5 126 ± 6* 
82± 9 60 ± 26* 
0.82 ± 0.06* 0.48 ± 0.20* 
27.43 ± 2.12 21.52 ± 5.93 
1.80 ± 0.41 * 1.97 ± 0.26* 
0.49 ± 0.09 1.21±0.37* 
2.55 ± 0.28 2.30 ± 0.45 
0.954 ± 0.008 0.903 ± 0.020* 
Data are means ± SEM for n = 3-5 rats in each group. * p<0.05 relative to 0 MS, 
one-way ANOVA with post-hoe analysis using Bonferroni's method. 3hr post-
injection, calf muscles were freeze clamped then excised from rats. 
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Figure 30: Effects of different doses of rnicrospheres (x 106 MS) on insulin-
mediated rnicrovascular recruitment. 
1-MX metabolism of the treated leg as a result of different doses of MS. Animals 
were left to equilibrate for one hour after the retrograde epigastric miery MS 
injection. Measurements were made at the end of a 2 hrs insulin infusion. Data are 
means ± SEM for n = 5-7 in each group. * p<0.05 relative to 0 MS, unpaired 
student t-test. 
o 0 MS, • 1.5 x106 MS, • 3 x106 MS, • 7 x106 MS. 
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5.3.3 Effects of MS Occlusion on Insulin-Mediated Glucose Disposal 
Four experimental groups were used to assess the effects of MS occlusion on 
insulin-mediated glucose uptake. The first two groups received the sham 
operation followed by a saline infusion (o Sham-Saline) or a 10 mU/kg/min 
insulin infusion (• Sham-Insulin). The final two groups received an epigastric 
injection of 3 x 106 MS followed by either a saline ( MS-Saline) or a 10 
mU/kg/min insulin infusion(• MS-Insulin). As such, the sham groups were used 
as controls for the effects of the MS occlusion. 
5.3.3.1 Hemodynamic Parameters 
Figure 31 shows the MAP and HR after saline or insulin infusions in both sham 
and MS treated groups. In all groups, no significant change in MAP or HR was 
observed. 
5.3.3. 1. 1 FBF in the Treated Legs 
FBF of the treated leg is shown in Figure 32A. The two sham groups yielded 
expected results with no observed change in FBF in the saline infusion and an 
increase in the FBF 40 min after the insulin infusion was begun. The difference 
between Sham-Saline and Sham-Insulin reached significance from 50 min 
onward. 
MS occlusion affected the FBF in two ways. First, MS occlusion itself produced 
an increase in basal FBF when compared to the sham group (at 0 min, Sham = 
0.82 ± 0.04 ml/min, MS = 1.34 ±0.05 ml/min, p<0.001 ). This effect was 
maintained and increased throughout the procedure, resulting in a significant 
increase in FBF at all time points during the MS-Saline compared to Sham-Saline 
experiments. This was also evident when comparing MS-Insulin and Sham-
Insulin, although the difference was no longer significant at 120 min (Sham-
Insulin = 1.89 ± 0.26 ml/min, MS-Insulin = 2.24 ± 0.24 ml/min, p=0.12) . Second, 
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the slight continual increase in FBF in MS-Saline group resulted in significant 
changes over basal levels from 75 min onward. During MS-Insulin experiments, 
the increase in FBF was apparent from 30 min onward. Higher FBF compared to 
sham in both MS groups meant that there was no significant difference between 
the MS-Saline and the MS-Insulin at any time points. 
5.3.3.1.2 FBF in the Contralateral Leg 
FBF in the contralateral leg is shown in Figure 32B. Insulin infusion elicited an 
increase in FBF at 40 min onward in the contralateral leg (both sham and MS) 
while saline infusion did not (both sham and MS). While FBF in Sham-Insulin 
was significantly different from Sham-Saline from 50 min onward, this was not 
the case in the MS groups. Unexpectedly, the insulin-mediated increase in FBF in 
the MS-Insulin group was not significantly different from MS-Saline group 
(p=0.08). 
5.3.3.2 Microvascular Recruitment 
Figure 33 depicts the microvascular recruitment at the end of the 2 h experiment 
in all four groups, for both the contralateral and the treated legs. The expected 
insulin-mediated increase in microvascular recruitment was observed in the 
contralateral leg when compared to the corresponding saline group. In the treated 
legs, sham treatment did not affect the insulin-mediated microvascular 
recruitment as seen from the conserved increase with insulin (Sham-Saline= 5.13 
± 0.34 nmol/min, Sham-Insulin= 8.99 ± 0.79 nmol/min, p<0.01). On the other 
hand, MS injection prevented the insulin-mediated increase in microvascular 
recruitment (Sham-Insulin= 8.99 ± 0.79 nmoVmin, MS-Insulin = 6.23 ± 0.75 
nmol/min, p<0.05). Of note, the MS occlusion did not affect the basal recruitment 
as 1-MX metabolism was similar in both saline infusion groups of the treated leg 
(Sham-Saline = 5.13 ± 0.34 nmol/min, MS-Saline = 4.64 ± 1.04 nmol/min, 
p=0.65). 
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Figure 31: Mean arterial pressure and heart rate during acute MS occlusion. 
Time course for mean arterial pressure (A) and heart rate (B) as a result of an 
acute MS occlusion. Mean arterial pressure and heart rate were measured by a 
catheter placed in the carotid artery. Data are means ± SEM for n = 6-7. 
Comparisons were made using two-way RM ANOV A. 
o Sham-Saline,• Sham-Insulin, MS-Saline, • MS-Insulin. 
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Figure 32: Femoral blood flow in both legs of rats during acute MS 
occlusion. 
Time course of femoral blood flow in the treated leg (A) and the contralateral leg 
(B) as a result of an acute MS occlusion. Flow probes were positioned around the 
femoral arteries of each leg. Data are means ± SEM for n = 6-7. * p<0.05 from 
saline of same treatment, two-way RM ANOVA with post-hoe analysis using 
SNK method. 
o Sham-Saline, • Sham-Insulin, MS-Saline, • MS-Insulin 
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Figure 33: 1-MX disappearance during acute MS occlusion. 
1-MX metabolism of the contralateral leg (left panel) and the treated leg (right 
panel) after an acute MS occlusion. Measurements were made at the end of a 2 
hrs insulin or saline infusion. Data are means± SEM for n = 5-6. * p<0.05 from 
saline of same treatment, # p<0.05 from Sham-Insulin, two-way ANOVA with 
post-hoe analysis using SNK method. 
o Sham-Saline,• Sham-Insulin, MS-Saline, • MS-Insulin. 
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5.3.3.3 Glucose Infusion Rate and Blood Glucose 
There was no significant difference in GIR between the Sham-Insulin and MS-
Insulin in response to the 10 mU/kg/min insulin infusion (23.5 ± 0.9 mg/kg/min 
and 22.8 ± 0.7 mg/kg/min, p=0.51 respectively) (Figure 34A). Additionally, the 
blood glucose did not change significantly at any time point for any of the four 
groups (Figure 34B). 
5.3.3.4 Muscle Glucose Uptake 
As expected, insulin elicited an increase in the disposal of glucose into the calf 
muscles of the contralateral leg (Figure 35A) in both the sham and the MS groups 
as seen by the increased disposal of radiolabeled 2-DG. 
In the treated leg, Sham-Insulin showed increased glucose uptake when compared 
to the Sham-Saline (Sham-Saline= 3.55 ± 0.14 µg/g/min, Sham-Insulin= 12.79 ± 
1.02 µg/g/min, p<0.001) (Figure 35A). However, MS occlusion by itself also 
increased glucose disposal as seen from the significant increase in the MS-Saline 
when compared to the Sham-Saline (Sham-Saline= 3.55 ± 0.14 µg/g/min, MS-
Saline = 11.01 ± 1.60 µg/g/min, p<0.001). Nevertheless, insulin still significantly 
increased glucose uptake in the MS-Insulin when compared to MS-Saline (MS-
Saline = 11.01 ± 1.60 µg/g/min, MS-Insulin= 16.07 ± 1.00, p<0.01). Assessment 
of the insulin-mediated increase in R'g (obtained by subtraction of saline R'g 
:from the insulin R' g), a 46 % reduction was observed in the MS treated legs when 
compared to the sham (5.06 ± 1.31 µg/g/min and 9.24 ± 0.76 µg/g/min, p<0.01 
respectively) (Figure 35B). 
5.3.3.5 Venous Plasma Lactate 
Figure 36 shows the plasma lactate of the venous samples in the treated legs of 
each of the four experimental groups. In the sham experiments, insulin induced 
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the expected increase in lactate release. Interestingly, MS occlusion itself induced 
an increase in venous lactate as seen in the MS-Saline treated leg. 
5.3.3.6 Higlt-Energy Intermediates 
Table 6 shows the high-energy intermediates assessed in the treated calf muscles 
of each group. Two results stand out. Firstly, decreases in the PCr/Cr ratio and in 
the total level of PCr occurred during MS occlusion, consistent with a decrease in 
blood delivery. Secondly, the EC was unaffected with a 3x106 MS occlusion, as 
observed in the previous study of the dose effect of MS occlusion (Table 5). 
5.3.3. 7 Tibia/is Anterior Muscle Fluorescence 
MS entrapment was assessed by measuring the fluorescence of MS in both legs of 
the MS treated rats. Similar levels of fluorescence were observed in the tibialis 
anterior muscle extracted from the MS-Saline and MS-Insulin treated legs (MS-
Saline = 4.05 ± 0.55 % of expected, MS-Insulin= 4.19 ± 1.00 % of expected, p = 
0.91). No significant fluorescence was observed in the contralateral leg. 
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Figure 34: Glucose infusion rate and blood glucose during acute MS 
occlusion. 
Time course for the glucose infusion rate (A) and the blood glucose concentration 
(B) as a result of an acute MS occlusion. Blood glucose levels were maintained at 
basal level (time 0 min). Data are means ± SEM for n = 6-7. Comparisons were 
made by a two-way RM ANOV A. 
o Sham-Saline, • Sham-Insulin, MS-Saline, • MS-Insulin 
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Figure 35: Muscle glucose uptake during acute MS occlusion. 
(A) Muscle radioactive 2-DG uptake (R'g) for both legs of each group as a result 
of an acute MS occlusion. 2-DG was administered as a bolus at 75 min (Figure 6) 
and calf muscles were excised at the completion of the experiment. o Sham-
Saline, • Sham-Insulin, MS-Saline, • MS-Insulin. (B) Insulin-mediated glucose 
uptake was calculated from the difference between Insulin and Saline 2-DG 
uptake in each treatment group. • Sham-Insulin minus Sham-Saline, • MS-
Insulin minus MS-Saline. Data are means ± SEM for n = 6-7. * p<0.05 from 
saline of same treatment, # p<0.05 from Sham-Saline, § p<0.05 from Sham-
Insulin, two-way ANOV A with post-hoe analysis using SNK method. 
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Figure 36: Venous plasma lactate in the treated leg during acute MS 
occlusion. 
Venous plasma lactate for the treated leg in response to an acute MS occlusion. 
Data are means ± SEM for n = 6. * p<0.05 from saline of same treatment. # 
p<0.05 from Sham-Saline, two-way ANOV A with post-hoe analysis using SNK 
method. 
o Sham-Saline, • Sham-Insulin, MS-Saline, • MS-Insulin. 
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Table 6: High-energy intermediate content of calf muscles from treated legs 
during acute MS occlusion. 
Sham- Sham- MS-Saline MS-Insulin Saline Insulin 
Dry wt/Wet wt 0.203 ± 0.007 0.211 ± 0.004 0.185 ± 0.007* 0.187 ± 0.004* 
Creatine 83 ± 3 83 ±4 91±9 94±5 (µmol/g dry weight) 
Phospho-
Creatine 121±5 117 ± 5 92±4* 91±5* 
(µmol/g dry weight) 
PCr/Cr 1.46 ± 0.07 1.42 ± 0.07 1.06 ± 0.13* 0.97 ± 0.05* 
ATP 29.27 ±0.95 29.45 ± 1.04 26.85 ± 1.63 25.58 ± 1.75 (µmol/g dry weight) 
ADP 3.38 ± 0.06 3.28 ± 0.23 3.04 ± 0.19 2.66 ± 0.15 (µmol/g dry weight) 
AMP 0.49 ± 0.11 0.27 ± 0.03# 0.28 ± 0.06 0.56 ± 0.07*# (µmol/g dry weight) 
NAD 3.06 ± 0.10 2.80 ± 0.09 2.67 ± 0.14 2.56 ± 0.17 (µmol/g dry weight) 
Energy Charge 0.934 ± 0.004 0.942 ± 0.004 0.940 ± 0.003 0.933 ± 0.005 
Data are means ± SEM for n = 6-7 rats in each group. * p<0.05, vs. corresponding 
Sham. # p<0.05, vs. corresponding Saline, two-way ANOV A with post-hoe 
analysis using SNK method. Calf muscles were freeze clamped then excised at 
the completion of each experiment. 
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5.4 DISCUSSION 
Results of the present study indicate that physical blockage of the 
microvasculature can prevent both hemodynamic and metabolic actions of insulin 
in skeletal muscle. One of the most significant discoveries was the 46 % decrease 
in insulin-mediated glucose uptake resulting from the impairment of the insulin-
mediated microvascular recruitment. 
The MS occlusion is a more advantageous approach than pharmacological 
treatments as it limits the skeletal muscle microvascular recruitment directly. 
Pharmacological blockage of the insulin-mediated microvascular recruitment 
required prolonged systemic infusions (Rattigan 1999, Youd 2000, Clerk 2002, 
Wallis 2005), thus extra-muscular effects cannot be excluded. MS occlusion 
effects are limited to the skeletal muscle, as the local injection would only block 
the microvasculature of the lower leg muscles. Therefore, MS occlusion is the 
only treatment that directly and specifically targets the microvasculature of the 
skeletal muscle. 
5.4.1 Effects of MS Occlusion on Hemodynamic Parameters 
The aim of the present experimental procedure was to assess if physical occlusion 
of the skeletal muscle microvasculature by MS can affect the insulin actions in 
this tissue. As such, the first aim was to show that the insulin-mediated 
microvascular recruitment was indeed impaired with the presence of MS. As 
shown in Figure 33, insulin-mediated microvascular recruitment was prevented 
by the MS occlusion (MS-Saline= 4.64 ± 1.04 nmol/min, MS-Insulin= 6.23 ± 
0.75 nmol/min, NS). Therefore, MS occlusion is akin to the impaired vascular 
actions of insulin at the terminal arterioles as seen in endothelial dysfunctional 
(Bakker 2009, Vanhoutte 2009). The arterioles of the fifth order, considered to be 
the terminal arterioles, would be the most likely to be blocked with 15µm MS 
(Murrant 2000). The acute physical occlusion of the terminal arterioles would 
mimic a functional rarefaction usually associated with impaired vasodilatory 
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response (Clerk 2004). Endothelial dysfunction prevents the insulin-mediated 
microvascular recruitment and the glucose disposal in the skeletal muscle (Baron 
1997) and has been implicated in the insulin resistant state (Kim 2006, Jansson 
2007). The partial occlusion of the microvasculature in the present study reduced 
the access of insulin to the myocyte and therefore decreases its effects to promote 
glucose uptake, in a similar manner to endothelial dysfunction. 
The similar basal level of 1-MX metabolism (Sham-Saline = 5.13 ± 0.34 
nmol/min, MS-Saline = 4.64 ± 1.04 nmol/min, p=0.65) may seem surprising 
given the fact that the MS occlusion will have blocked parts of the 
microvasculature. The explanation for this relies on the ischemic state that has 
been induced by the MS occlusion. Ischemia is known to increase microvascular 
recruitment (Parthasarathi 1999). Blocked capillary beds may cause the tissues to 
become ischemic and secrete factors that promote microvascular blood flow 
(Noon 1997, Bertuglia 2005). These secreted factors can migrate to the 
surrounding tissue and could act on the non-occluded terminal arterioles. These 
may then open, and allow previously closed capillary beds to be perfused. 
Therefore, the basal level of microvascular recruitment after the MS occlusion 
will be similar to the basal level of the sham treated leg. 
Basal FBF was increased by the presence of MS (Sham= 0.82 ± 0.04 ml/min, MS 
= 1.34 ±0.05 ml/min, p<0.001) (Figure 32A). This increase in FBF may be due to 
an ischemic state resulting from the MS occlusion. Additionally, FBF in both the 
MS-Saline and MS-Insulin groups increased over time and no significant 
difference was evident between these two groups. Therefore, the expected insulin-
mediated increase in FBF was prevented by the MS occlusion. FBF was also 
affected in the contralateral legs by the MS occlusion of the treated legs (Figure 
32B). Insulin-mediated increase in FBF was still present in the MS-Insulin group, 
with a tendency of the MS-Insulin group to be increase when compared to the 
MS-Saline group (p=0.08 at 120 min). Hence, insulin may have failed to induce a 
significant increase in FBF when the microvasculature was occluded. 
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5.4.2 Effects of MS Occlusion on Metabolic Parameters 
The most significant finding from the present study is that prevention of the 
insulin-mediated microvascular recruitment led to a 46 % decrease in insulin-
mediated glucose uptake (Figure 35B). It is important to acknowledge that an 
increased glucose disposal was observed during the MS occlusion itself, as 
showed by a significant increase in R'g in MS-Saline compared to Sham-Saline 
(Sham-Saline = 3.55 ± 0.14 µg/g/min, MS-Saline = 11.01 ± 1.60 µg/g/min, 
p<0.001). This effect can be attributed to ischemia. As the muscle begins to rely 
more on anaerobic metabolism, an increase in glucose uptake occurs in order to 
sustain the metabolic needs of the muscle. As a consequence, the level of glucose 
uptake in the MS-Saline increases to a similar extent as the insulin response in the 
sham group (Sham-Insulin= 12.79 ± 1.02 µg/g/min, MS-Saline= 11.01 ± 1.60 
µg/g/min, NS). Insulin and ischemia have been reported to have an additive effect 
on glucose uptake (Azevedo 1995). Therefore, the effect of insulin alone can be 
calculated by subtracting the glucose uptake of the MS-Saline (ischemia-mediated 
glucose uptake) from the glucose disposal of the MS-Insulin (ischemia- and 
insulin-mediated glucose uptake). Thus, levels of insulin-mediated glucose uptake 
were decreased during MS occlusion (Figure 35B). Therefore, occlusion of the 
microvasculature reduced the insulin-mediated glucose uptake, creating an acute 
state of vascular-derived insulin resistance. 
The unchanged basal blood glucose and the normal GIR (Figure 34) indicate that 
whole body insulin sensitivity was unaffected. This was not surprising as only a 
portion of the muscle mass of the treated leg would be affected by local MS 
occlusion, leaving the remainder of the muscle mass available for the actions of 
insulin. 
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5.4.3 MS Occlusion and Other Acute States of Vascular Derived Insulin 
Resistance 
It is interesting to compare data of the present study to the effects of acute 
infusion of TNF-a. The levels of this cytokine have been observed to increase in 
the insulin resistant state (Hotamisligil 1995, Hotamisligil 1999, Xu 2002, Torres 
2004) and have been shown to prevent insulin's intracellular signalling at 
different levels (Plomgaard 2005, Li 2007). Studies using a one hour pre-infusion 
of TNF-a before a hyperinsulinaemic clamp have impaired the insulin-mediated 
microvascular recruitment (Youd 2000). It was also observed that the insulin-
mediated increase in FBF and microvascular recruitment was fully blunted, with a 
concomitant decrease of approximately 50 % of the insulin-mediated glucose 
uptake. Comparison between TNF-a infusion and MS occlusion revealed that 
only the GIR was different. Interestingly, TNF-a infusion induced a 21 % 
decrease of the GIR while MS occlusion did not have significant effect on the 
GIR. As the TNF-a infusion was systemic it would have affected the entire 
muscle mass, while the MS occlusion was local and limited to the muscles of one 
leg. Moreover, extra-muscular systemic effects of TNF-a cannot be excluded. 
TNF-a effects on liver (Lang 1992) and/or adipose tissue (Hotamisligil 1994) 
could have occurred, resulting in a decrease in the GIR. MS occlusion effects 
would be limited to the skeletal muscle, as the local injection would restrict the 
blockage to the microvasculature of the lower leg muscles. Therefore, the MS 
occlusion provides a novel and more direct model for determining the 
microvascular contribution to muscle insulin resistance. 
The similarities between MS occlusion and TNF-a infusion are also reflected in 
other acute states of vascular derived insulin resistance. Indeed, a-
methylserotonin (Rattigan 1999), increased circulating FFA (Clerk 2002), and 
glucosamine (yv allis 2005) have all been shown to block the insulin-mediated 
microvascular recruitment and as much as 50 % of the insulin-mediated glucose 
disposal. Similar to the TNF-a infusion, these treatments also impaired the 
systemic action of insulin, as evidenced by decrease in the GIR during the insulin 
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clamp procedure. MS occlusion is then the only treatment that directly and 
specifically targets the microvasculature of the skeletal muscle. 
5.4.4 MS Occlusion Induced Ischemia 
As described above, it was also apparent that a mild ischemic state had been 
created by the MS occlusion of the muscle microcirculation. Ischemia occurs 
when the supply of arterial blood is insufficient to maintain the metabolic needs 
of the tissue. This results in a shift toward anaerobic metabolism to maintain the 
ATP levels required for normal function of the skeletal muscle. Three parameters 
clearly indicate that an ischemic state was induced by the MS occlusion. First, 
there was a decrease in the PCr/Cr ratio (Table 6). This parameter is frequently 
used as an indicator of blood delivery to the skeletal muscle (Ye 1996). Myocytes 
utilize their PCr store to maintain a constant ATP level (Boron 2003). As the 
selection for the dose of MS was made based on a decrease in PCr/Cr ratio, this 
decrease was anticipated (Table 5). The second marker of ischemia is the 
presence of oedema, as seen by a slight but significant decrease in the dry 
weight/wet weight ratio (Table 6). Accumulation of water in the interstitial space 
is a known consequence of ischemia, resulting from a change of hydrostatic 
pressure and increased permeability of capillaries (Kasner 1997). The third 
indicator of ischemia is the increase in lactate production (Figure 36). As the 
basic metabolic needs of the ischemic muscle shift from oxidative 
phosphorylation to glycogen metabolism, there is an increase in the amount of 
lactate released. Overall, these parameters indicate that an ischemic state resulted 
from MS occlusion. Insulin action during the MS occlusion must then be analysed 
with regard to the effect of the ischemia per se. Correspondingly, comparisons 
with the MS-Saline were made in order to assess the effect of insulin alone during 
the partial occlusion of the skeletal muscle microvasculature. 
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5.4.5 MS Occlusion: In vivo vs. Perfused Hindlimb 
Previous studies of hindlimb perfusion preparations established the effect of MS 
occlusion on insulin-mediated glucose uptake (Vollus 2007). In this preparation, 
MS occlusion prevented the insulin-mediated glucose uptake. While hindlimb 
perfusion generated very interesting data, it still represents an in situ preparation 
where the vasculature is fully dilated, and as such, may not accurately represent 
the normal in vivo blood flow distribution. Therefore, the assessment the MS 
occlusion in an in vivo model was critical to our understanding of the 
physiological importance of the microvasculature in insulin-mediated glucose 
disposal. 
In the in vivo model, similarly to the hindlimb perfusion, presence of MS in the 
skeletal muscle microvasculature prevented the insulin-mediated glucose uptake 
(Figure 35). Thus, both models provide support for a role of the microvasculature 
in insulin-mediated glucose uptake. However, the hindlimb perfusion differs from 
the in vivo in its effect of the occlusion on basal glucose uptake. The basal level 
of glucose uptake in the hindlimb perfusion was unaffected (Vollus 2007) 
whereas an increase in glucose uptake occurs in the in vivo model in response to 
the ischemic state (Figure 35A). As there was an increase in phosphorylation of 
AMPK in the perfused hindlimb, this is indicative of a degree of ischemia. One 
explanation for the difference in basal glucose uptake could the lower temperature 
of the perfusion setting (32°C). Temperature would affect the rate of metabolism, 
while the delivery of insulin is only important in insulin-mediated glucose uptake. 
However, it is more likely that the difference results from different microvascular 
distribution ofthe MS in the two systems. In the hindlimb perfusion, MS were 
injected over 2 sec in the descending aorta while in the in vivo model a retrograde 
injection over 10 sec was made in the epigastric artery. This means that MS 
would have lodged in a much larger muscle mass in the hindlimb perfusion and 
than in the in vivo model, where the MS would be localised in the lower leg 
muscle. This divergence in the muscle localisation of the MS could be responsible 
for the difference in basal glucose uptake. 
120 
CHAPTERS: 
ACUTE MICROSPHERE OCCLUSION INDUCED VASCULAR INSULIN 
RESISTANCE 
Differences were also observed between the models in the high-energy 
intermediates content. In the perfused hindlimb, all doses of MS decreased the 
PCr/Cr ratio in a dose dependent fashion (Vollus 2007), while in the in viva 
model the PCr/Cr ratio was affected only at the higher doses of 3 and 7 x106 MS 
(Table 5). Furthermore, the EC remained unchanged in the hindlimb perfusion 
while a significant decrease was observed in viva at the highest dose of 7 x106 
MS. A plausible explanation might reside in the time of the muscle excision. In 
the perfused hindlimb experiments, the high-energy intermediate determinations 
were made 10 min post-occlusion, while 3 hours had passed in the in viva model. 
10 min is unlikely to affect the EC. However, the increases in AMPK 
phosphorylation in the perfused muscle indicate that an ischemic state may have 
been created. In addition, distinctions in the high-energy intermediate may also 
results from the perfusion states of each model. The vasculature in the hindlimb 
perfusion preparation represents a fully perfused state while only a third of the 
microvasculature is perfused at the basal level in the in viva model (Honig 1982). 
This means that even with the occlusion of some of the vessels in the hindlimb 
perfusion, the majority of vessels still received glucose preventing a decrease in 
the EC. The in viva occlusion may prove more important in terms of 
microvascular delivery than in the hindlimb perfusion. Furthermore, as discussed 
above, the divergence in injection site and the subsequent difference in muscle leg 
localisation may also be responsible for the difference in the high-energy 
intermediates content. All of these factors could explain the different high-energy 
intermediates results. Nevertheless, both preparations showed an impairment of 
insulin-mediated glucose uptake during MS occlusion of the microvasculature. 
5.4.6 Study Design and Future Experiments 
Limitations of the present study design need to be acknowledged. One of these is 
how the dose of MS to be injected was determined. While the determination was 
based on many parameters (high-energy intermediate profile, microvascular 
recruitment, impaired insulin-mediated glucose uptake in the hindlimb perfusion), 
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the effect on the basal blood flow should have been considered more. The ideal 
dose of MS would have been one that would have eliminated the insulin-mediated 
microvascular recruitment without affecting the resting blood flow. However, the 
lower dose of l .5xl 06 MS failed to prevent the insulin-mediated microvascular 
recruitment. Further experiments using higher doses of MS (2.0 and 2.5x106 MS) 
should be done to assess if the insulin-mediated microvascular recruitment can be 
blocked without affecting the basal FBF. Another limitation of the present study 
is the lack of information about the spatial distribution of the injected MS. This 
limitation could be resolved by observing the three-dimensional distribution of 
individual MS in representative muscles using a Fluorescent Imaging 
CryoMicrotome (Vincent 2001 ). This would also enable the assessment of the 
histological effects of the MS occlusion on the surrounding tissue (i.e. 
inflammatory response, necrosis, etc). 
The question of the route occluded (nutritive vs. non-nutritive) by the MS is a 
critical component of the present study. Another limitation of the study design is 
that the injection of the MS was done in the basal state when mostly the non-
nutritive route is considered to be perfused (Clark 2000). As the insulin-mediated 
glucose uptake occurs principally in the nutritive route, injection of MS at rest 
may not have sufficiently blocked this route. This issue was partly addressed by 
preventing the access of blood to the foot during the MS injection. Preliminary 
experiments have shown that epigastric artery injection of MS in the unrestrained 
state failed to localise the MS within the lower leg muscles. Using a haemostatic 
clamp, blood flow passing through the large shunt vessels in the foot was 
prevented. Therefore, the MS were redirected toward the leg muscles. Although 
the actual route that the blood flow is redirected to is unknown, an increased 
proportion of the nutritive route of the skeletal muscle would likely have been 
perfused, and subsequently blocked by the MS injection. 
Since in the present design it is unknown which flow route was blocked, future 
studies targeting the occlusion of the nutritive route could be undertaken. This 
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could be achieved in two ways. First, by stimulating an increase in microvascular 
recruitment with insulin prior to MS injection. This would have the advantage of 
blocking the vessels that are recruited by insulin. Another way would be to make 
the muscle contract using electrical stimulation as the nutritive route is known to 
be recruited during muscle contraction (Clark 2000). Overall, both stimuli would 
enable a more direct assessment of a blockage of the nutritive route on the 
insulin-mediated glucose uptake. More targeted blockage of the nutritive route 
may require less MS, and as such, decrease the ischemic response currently seen. 
This would allow for clearer interpretations of insulin-mediated muscle glucose 
disposal. 
Overall, this study demonstrated the importance of the microvasculature as a 
target for insulin action. By preventing the insulin-mediated increase in skeletal 
muscle microvascular recruitment, insulin-mediated glucose uptake was 
decreased. Therefore, acute MS occlusion can be viewed as a functional defect, 
mimicking the initial stage of insulin resistance. This model provides a paradigm 
for examining the effects of long-term impairment of microvascular recruitment 
in relation to the development of metabolic insulin resistance within skeletal 
muscle and type 2 diabetes. 
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6.1 INTRODUCTION 
Skeletal muscle is a prime target for early defects in the development of insulin 
resistance (Reaven 1988, Defronzo 1991), although the exact mechanisms 
remain largely unknown. That myocyte insulin resistance occurs in fully 
established type 2 diabetes is without question (Defronzo 1985, Zierath 1998, 
Ryder 2001, Karlsson 2007). However it is not clear whether myocyte insulin-
signalling defects are the sole cause of skeletal muscle insulin resistance 
(Karlsson 2007). There is evidence that vascular dysfunction precedes, and may 
contribute to the development of insulin resistance in the muscle (Jansson 2007, 
Seme2007). 
Impairment of insulin signalling in the vasculature has been shown to precede 
skeletal muscle insulin resistance (Youngren 2001, Kim 2008). Impairment in 
insulin-mediated Akt phosphorylation in endothelial cells occurs after two weeks 
of HFD feeding, while four weeks feeding is needed for this impairment to be 
present in the skeletal muscle. Furthermore, diminished NO signalling, 
responsible for the vasodilatation action of insulin in first-order arterioles from 
the gastrocnemius muscle, precede the development of diabetes and 
hypertension in ZDF rats (Lesniewski 2008). These findings indicate that loss of 
insulin action in vasculature precedes the muscle insulin resistance. 
Decreased insulin action in the vasculature will affect the insulin-mediated 
microvascular recruitment. Impairment in insulin-mediated microvascular 
recruitment is present in animal models of type 2 diabetes (Wallis 2002, Clerk 
2007) and in obese patients (Clerk 2006), as well as in the early stage of insulin 
resistance, as shown in chapter 3. Impainnent of insulin-mediated microvascular 
recruitment as an early event may be responsible for the development of whole 
body insulin resistance in the later stage of type 2 diabetes (Defronzo 1985). 
Pharmacological blockages of the insulin-mediated microvascular recruitment 
have also been shown to impair more than 50% of the insulin-mediated skeletal 
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muscle glucose uptake (Rattigan 1999, Youd 2000, Clerk 2002, Wallis 2005). 
These treatments required systemic infusion and have been shown to affect 
tissues other than the skeletal muscle, therefore they are not ideal for chronic 
study of the muscle microvasculature. A more appropriate model would be the 
MS occlusion of the skeletal muscle microvasculature. As shown in the previous 
chapter, physical blockage of the skeletal muscle microvasculature led to an 
acute vascular-derived state of insulin resistance. This model used chronically 
could help inform on the importance on the microvasculature in the development 
of muscle and myocyte insulin resistance. 
Therefore, the present study aims to assess the effects of a chronic impairment of 
insulin-mediated microvascular recruitment on skeletal muscle insulin 
sensitivity. The hypothesis is that an impairment of the skeletal muscle 
microvasculature would lead to the myocyte insulin resistance seen in fully 
established type 2 diabetes. 
6.2 MATERIAL AND METHODS 
6.2.1 Recovery Surgery 
Hooded Wistar rats weighing 250 grams were anesthetised using a Stinger 
apparatus (Advance Anaesthesia Specialist, Sydney, Australia). Rats were 
placed in a bucket with lid where the tube of the Stinger was inserted. The 
oxygen rate was at 4 1/min and the isoflurane vaporiser (lml/ml, VCA, NSW, 
Australia) set at 4 %. Once the rat was unresponsive to touch, it was transferred 
to the preparation area. The nozzle of the anaesthetic apparatus was placed over 
the head of the rat and the oxygen rate was set at 0.8 1/min and the anaesthetic 
vaporiser at 2 % for the remainder of the procedure. The left leg was shaved and 
cleaned with the antiseptic solution Benamine (7.5 % w/v Povidone-Iodine, 
Paulding Pharmaceuticals, Australia). The animal was then transferred to the 
surgery table for the remaining of the procedure. A sterile cloth, containing a 
small window for leg access, was placed over the rat. A small incision of about 1 
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cm was made on the overlying skin of the femoral vessels. The epigastric artery 
cannulation for the 3x106 MS injection was undertaken as described in section 
5.2.3. Since this experiment required recovery surgery, special care was taken to 
ensure the sterility of the procedure and reduce the risk of post-surgery 
complications. 
Once the MS injection procedure was completed, the wound was closed using a 
braided polyglycolic acid synthetic absorbable surgical suture (3-0 Dexon II, 
Sherwood Medidal, USA). The animal was then removed from the isoflurane 
inhalation apparatus, and allowed to recover in a 32°C heated cage. Thereafter, 
rats were housed two per cage for a period of 2 weeks and were monitored 
throughout the recovery process. Of note, no observable ill effects from the 
procedure, such as loss of mobility or necrosis, were observed in any of the 
animals used. They were kept as described in section 2.1. 
At the end of the 2 weeks chronic occlusion, rats weighed 291 ± 3 g, with no 
significant difference between sham and MS treated animals. Rats used in these 
experiments were not fasted, as the determination of whole body glucose 
kinetics was not required. 
6.2.2 In vivo Surgery 
Two weeks post-injection, in viva experiments were conducted using the 
anaesthetised rat model, with surgery as described in section 2.2.1. 
6.2.3 Experimental Procedure 
The chronic effect of MS embolism on the skeletal muscle microvasculature was 
assessed during an isoglycaemic hyperinsulinaemic clamp as described in 
section 2.2.2. Briefly, 1-hour after the surgical procedure, saline or insulin (10 
mU/min/kg) was infused into the rat and continued for 2 hours (Figure 6). 
During experiments involving insulin infusion, a glucose solution (30 % w/v) 
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was also infused at variable rates to maintain blood glucose levels at around 
basal levels. Femoral artery blood flow was continuously measured with a 
Transonic® flow probe positioned around the femoral artery of both the treated 
and the contralateral legs. 1-MX disappearance was used as an indicator of 
perfused capillary surface area as described in section 2.2.3.5. A bolus dose of 
[3H] 2-DG (50 µCi) was given 45 min before the end of the experiment. Calf 
muscles were excised at the completion of the experiment and freeze clamped in 
liquid nitrogen to assess the 2-DG uptake as described in section 2.2.3.3. 
6.2.3.1 High-Energy Intermediates 
Powdered calf muscles were used to assess the high-energy intermediates. 
Extraction and measurement were done as described in section 2.2.3. 7. 
6.2.3.2 Fluorescence 
Tibialis anterior muscle from both legs were excised at the end of the 
experimental procedure and kept at -20 °C until the fluorescence was assessed as 
described in section 5.2.4.2. 
6.2.4 Data Analysis 
All data are expressed as means ± SEM. Data were calculated as described in 
section 2.2.4. Comparisons were made between treatment groups over the course 
of the experiment using two-way non-repeated or repeated-measures ANOV A 
with Student-Newman-Keuls post hoe test as mentioned in the corresponding 
figure legend. All tests were performed using the SigmaStat statistical program 
(Systat Software Inc, CA, USA). 
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6.3 RESULTS 
Four experimental groups were used to assess the effects of MS occlusion on the 
insulin-mediated glucose uptake. The first two groups received the sham 
operation two weeks prior to either a saline infusion (o Sham-Saline) or a 10 
mU/kg/min insulin infusion (• Sham-Insulin). The other two groups received an 
epigastric injection of 3 x106 MS two weeks prior to either a saline ( MS-
Saline) or a 10 mU/kg/min insulin infusion ( • MS-Insulin). As such, the Sham 
groups were used as controls for the effects of the MS occlusion. 
6.3.1 Hemodynamic Parameters 
Figure 37 shows the MAP and HR after saline or insulin infusion in both the 
sham and MS treated groups. ln all groups, no significant change in MAP or HR 
occun-ed, except for a slight significant increase from basal of MAP in the MS-
lnsulin group after 120 min of experiment (Figure 37A). 
6.3.J.J FBF in Treated Leg 
FBF in the treated legs are shown in Figure 38A. ln the sham animals, there was 
no change in FBF during the saline infusion. An increase in the FBF occun-ed 
after 40 min in the Sham-Insulin group, with a significant difference from Sham-
Saline from that point onward. 
Similar results were obtained in the chronically MS occluded legs , with an 
insulin-mediated increase in FBF at 30 min onward in the MS-Insulin group, 
which was significantly different from the MS-Saline group from 50 min 
onward. 
6.3.J.2 FBF in Contralateral Legs 
In the contralateral leg (Figure 38A), insulin induced increase in FBF in both 
Sham-Insulin and MS-Insulin groups from 30 min onward. These increases were 
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significantly increased from their respective saline group at 40 min onward for 
the Sham-Insulin and at 75 min onward for the MS-Insulin. 
6.3.2 Microvascular Recruitment 
Figure 39 depicts the microvascular recruitment at the end of the 2 h experiment 
in all four groups, for both the contralateral and the treated legs. In the 
contralateral leg of all groups, the expected insulin-mediated increase in 
microvascular recruitment was apparent when compared to the corresponding 
saline group. In the treated leg, Sham-Insulin had a significant increase in 
microvascular recruitment compared to the Sham-Saline (Sham-Saline = 5.02 ± 
0.90 nmol/min, Sham-Insulin= 10.33 ± 1.33 nmol/min, p<0.01). Unexpectedly 
for a MS occlusion model, an insulin-mediated increase in microvascular 
recruitment was also observed in the MS treated leg (MS-Saline = 6.29 ± 0.60 
nmol/min, MS-Insulin= 9.47 ± 1.57 nmol/min, p<0.05). This implies that the 
chronic presence of MS does not impair insulin-mediated microvascular 
recruitment, in contrast to what was observed in the acute occlusion (Figure 33). 
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Figure 37: Mean arterial pressure and heart rate in chronic MS treated 
rats. 
Time course for mean arterial pressure (A) and heart rate (B) as a result of a 
chronic MS occlusion. Data are means ± SEM for n = 6-8. Comparisons were 
made using two-way RM ANOV A. 
o Sham-Saline,• Sham-Insulin, MS-Saline, • MS-Insulin. 
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Figure 38: Femoral blood flow in chronic MS treated rats. 
* 
120 
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120 
Time course of femoral blood flow in the treated leg (A) and the contralateral leg 
(B) as a result of a chronic MS occlusion. Data are means ± SEM for n = 6-8. * 
p<0.05 from saline of same treatment, two-way RM ANOV A with post-hoe 
analysis using SNK method. 
o Sham-Saline,• Sham-Insulin, MS-Saline, • MS-Insulin. 
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Figure 39: Microvascular recruitment in chronic MS treated rats. 
1-MX metabolism of the contralateral leg (left panel) and the treated leg (right 
panel) after an chronic MS occlusion. Measurements were made at the end of a 2 
hrs insulin or saline infusion. Data are means ± SEM for n = 6-8. * p<0.05 from 
saline of same treatment, two-way ANOVA with post-hoe analysis using SNK 
method. 
o Sham-Saline,• Sham-Insulin, MS-Saline, • MS-Insulin. 
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6.3.3 Glucose Infusion Rate and Blood Glucose 
There was no significant difference in GIR between the Sham-Insulin and MS-
Insulin groups in response to the lOmU/kg/min insulin infusion (20.6 ± 0.9 
mg/kg/min and 21.9 ± 1.4 mg/kg/min, p=0.43 respectively) (Figure 40A). Blood 
glucose did not significantly change in any of the groups, except for a small 
increase from basal in the Sham-saline group from 90 min onward (Figure 40B). 
6.3.4 Muscle Glucose Uptake 
As expected in the contralateral leg, insulin elicited an increase in glucose 
uptake into the calf muscles (Figure 41) in both the sham and the MS groups, as 
seen by the increased disposal of radiolabeled 2-DG. In the treated leg, glucose 
uptake in both the sham and MS groups responded normally to the insulin 
infusion. While surprising in an occlusion setting, it is consistent with the 
preserved effect of the increased microvascular recruitment by insulin (Figure 
39). 
6.3.5 Plasma Lactate 
No change in venous plasma lactate concentration was observed 14 days after 
the MS treatment (Figure 42). Insulin increased lactate release to the same extent 
in both sham and MS treated legs. 
6.3.6 Tibialis Muscle Fluorescence 
Fluorescence was assessed in the tibialis anterior muscle of both legs of MS 
treated rats. As seen in Figure 43, levels of fluorescence after 2 weeks occlusion 
were similar to those observed in the acute treatment (Acute MS= 4.12 ± 0.57 % 
of expected, Chronic MS= 3.30 ± 0.70% of expected, p = 0.37). 
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6.3.7 High-Energy Intermediates 
As seen in Table 7, the high-energy intermediates were not affected by the 
chronic presence of MS. The decrease in PCr, PCr/Cr ratio and dry weight/wet 
weight ratio observed in the acute MS occlusion (Table 6) were absent in the 
chronic occlusion. 
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Figure 40: Glucose infusion rate and blood glucose in chronic MS treated 
rats. 
Time course for the glucose infusion rate (A) and the blood glucose 
concentration (B) as a result of a chronic MS occlusion. Blood glucose levels 
were maintained at basal level (time 0 min). Data are means ± SEM for n = 6-8. 
Comparisons were made by a two-way RM ANOV A with post-hoe analysis 
using SNK method. 
o Sham-Saline, • Sham-Insulin, MS-Saline, • MS-Insulin. 
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Figure 41: Muscle glucose uptake in chronic MS treated rats. 
Muscle radioactive 2-DG uptake (R'g) for the contralateral leg (left panel) and 
the treated leg (1ight panel) of each group as a result of a chronic MS occlusion. 
2-DG was administered as a bolus at 75 min (Figure 6) and calf muscles were 
excised at the completion of the experiment. Data are means ± SEM for n = 6-8. 
* p<0.05 from saline of same treatment, two-way ANOVA with post-hoe 
analysis using SNK method. 
o Sham-Saline, • Sham-Insulin, MS-Saline, • MS-Insulin. 
137 
CHAPTER 6: 
CHRONIC EFFECT OF MICROSPHERE OCCLUSION 
Venous Plasma Lactate 
1.4 
* 
1.2 
1.0 
-
-0 0.8 E 
E 0.6 
-
...J 
a. 
0.4 
0.2 
0.0 
Treated Leg 
Figure 42: Venous plasma lactate in the treated leg during chronic MS 
occlusion. 
Venous plasma lactate for the treated leg in response to a chronic MS occlusion. 
Data are means ± SEM for n = 6-8. * p<0.05 from saline of same treatment, two-
way ANO VA with post-hoe analysis using SNK method. 
o Sham-Saline, • Sham-Insulin, MS-Saline, • MS-Insulin. 
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Figure 43: Tibialis anterior fluorescence in acute and chronic MS occlusion. 
Fluorescence intensity of the tibialis anterior for the contralateral leg ( o) and the 
MS treated leg(• ) in response to an acute (left panel) and a chronic (right panel) 
MS occlusion. Fluorescence of MS-Saline and MS-Insulin were combined to 
compare the acute and the chronic models. Data are means ± SEM for n = 11. 
Comparisons were made with a one-way ANOV A. 
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Table 7: High-energy intermediate content of calf muscles from treated legs 
following chronic MS occlusion. 
Sham-Saline Sham-Insulin MS-Saline MS-Insulin 
Dry wt/Wet wt 0.206 ± 0.007 0.212 ± 0.003 0.206 ± 0.004 0.202 ± 0.007 
Crea tine 74±6 66±2 68± 3 69±6 (µmol/g dry weight) 
Phospho-
Crea tine 121 ±4 111±3 119±0.04 105 ± 8 
(µmol/g dry weight) 
PCr/Cr 1.67 ± 0.12 1.67 ± 0.08 1.77 ± 0.06 1.54 ± 0.14 
ATP 29.46 ± 1.13 26.23 ± 0.40 29.76 ± 1.11 26.40 ± 2.14 (µmol/g dry weight) 
ADP 3.12 ± 0.24 3.30 ± 0.12 3.66 ± 0.18 3.22 ± 0.27 (µmol/g dry weight) 
AMP 0.51±0.10 0.36 ± 0.07 0.30 ± 0.04 0.31±0.08 (µmol/g dry weight) 
NAD 3.00 ± 0.09 2.66 ± 0.08 3.04 ± 0.12 2.67± 0.24 (µmol/g dry weight) 
Energy Charge 0.937 ± 0.004 0.933 ± 0.002 0.937 ± 0.002 0.936 ± 0.002 
Data are means ± SEM for n = 6-8 rats in each group. Comparisons were made 
with a two-way ANOV A. Calf muscles were freeze clamped then removed from 
rats at the completion of each experiment. 
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6.4 DISCUSSION 
The main observation from the current study was that chronic MS occlusion of 
the skeletal muscle microvasculature did not result in skeletal muscle insulin 
resistance. The lack of myocyte insulin resistance resulting from the occlusion 
does not mean that the microvasculature is not important. After the 2 week 
treatment, occluded muscle had adapted to the condition and impaired 
microvascular recruitment was no longer apparent. 
The indication of a reversal of the MS occlusion comes from the normal insulin-
mediated microvascular recruitment in the chronic model, contrasting with the 
impairment in the acute model of MS occlusion. Consequently, the decrease in 
insulin-mediated glucose uptake observed in the acute model was not conserved 
after 2 weeks of recovery, leading to normal insulin responses. The insulin-
mediated effects on metabolism, as seen with GIR, HGU and muscle R' g, and 
the vascular responses FBF and 1-MX disappearance, were unaffected by a 
chronic MS occlusion. Further differences to the acute model were also noted. 
All signs of ischemia indentified in the acute model (decreased PCr/Cr ratio, 
decreased dry weight/wet weight ratio, increased muscle lactate production and 
increased basal FBF) were absent in the chronic MS occlusion model. 
A possible explanation for the loss of occlusion in the chronic MS model could 
be that the MS are no longer localised within the skeletal muscle. Entrapment of 
the MS was verified by the inclusion of fluorescent MS in the 3 x 106 MS mix. 
Fluorescence analysis revealed that the MS were still present within the tibialis 
anterior muscle 2 weeks post-injection (Figure 43). Furthermore, the extent of 
the fluorescence was similar to the level recovered in the acute model. This 
means that the fluorescent MS are still present to a similar extent as in the acute 
model. 
It is likely that the muscles have adapted to the chronic MS occlusion by 
inducing the growth of new vessels, a phenomenon called angiogenesis (Brown 
140 
CHAPTER6: 
CHRONIC EFFECT OF MICROSPHERE OCCLUSION 
2003, Bloor 2005, Ferrara 2009). Growth of new vessels may have bypassed the 
occluded vessels and reversed the decreased microvascular blood delivery. Such 
an adaptation to the chronic presence of MS would have overcome the effects of 
the acute MS occlusion. 
Angiogenesis occurs with large vessel ligation (Milkiewicz 2003), but since 
occlusion with 15 µm MS was expected to only affect the microcirculation, 
angiogenesis was not anticipated. However, the results indicated that an 
ischemic state occurred acutely with the MS injection. It is known that similar 
ischemic states lead to angiogenesis (Walder 1996, Milkiewicz 2003, Ferrara 
2004, Economopoulou 2009, Hudlicka 2009). Therefore, additional experiments 
were conducted in our laboratory to confirm whether angiogenesis had occurred 
following the MS occlusion. Vascular Endothelial Growth Factor (VEGF) is the 
main molecule involved in the initiation and the control of angiogenesis (Leung 
1989, Brown 2003, Ferrara 2009). Therefore, messenger RNA ofVEGF and its 
receptor FLK-1 were measured by RT-PCR in the tibialis anterior muscle after 3 
hrs, 2, 4 and 14 days post MS occlusion. It was observed that a 2.3-fold increase 
in VEGF expression and a significant 11-fold increase in FLK-1 expression 
occurred 4 days after the MS occlusion. As an increase in the expression of 
VEGF receptor has been shown to be upregulated during angiogenesis 
(Milkiewicz 2003), this supports the proposal of angiogenesis as the adaptation 
that has occurred in the muscle to overcome the microvascular occlusion 
following the MS injection. Further assessment of the angiogcnic response needs 
to be done, either through quantitative histology (capillary: fibre ratio) or through 
blood flow imaging. 
These findings are similar to the ischemia-induced angiogenesis that has been 
previously reported due to large vessel ligation. Iliac artery ligation has been 
shown to increase muscle VEGF mRNA levels 1 and 3 days post ligation 
(Milkiewicz 2006). After 7 days of ligation, the levels of VEGF mRNA had 
returned to basal, and a decrease in VEGF mRNA was observed between 14-35 
days post-ligation as a counter regulatory mechanism (Milkiewicz 2006). 
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However, VEGF alone might not be as useful an index of angiogenic potential in 
response to ischemia as previously thought (Hudlicka 2009). Indeed, expression 
ofVEGF receptors (Flk-1 increases angiogenesis, while Flt-1 prevents) has been 
shown to be crucial in the onset and control of angiogenesis (Milkiewicz 2003), 
with activation of the VEGF receptor Flk-1 also observed to be an important 
factor in the induction of capillary growth (Abumiya 2002). 
The formation of new functional vessels after only 2 weeks of MS occlusion 
may seem rather rapid when compared with the capillary growth that occurs 
after large vessel ligation. Indeed, iliac ligation induces a late onset 
angiogenesis, with capillary:fibre ratio increased only after 35 days (Milkiewicz 
2003, Milkiewicz 2006). Interestingly, ligation of the smaller feeding arteriole of 
the caudal-half of the spinotrapezius muscle led to a 24 % increase in the 
formation of new arterioles after only 5 days (Bailey 2008). Therefore, a more 
proximal ligation of the arteries to the microcirculation seems more efficient in 
promoting the angiogenic process. As the occlusion with MS most likely 
occurred in the terminal arterioles, the induction of angiogenesis would be 
expected to be quicker than that following ligation of the iliac artery. 
In conclusion, the influence of the microvasculature on the development of 
myocyte insulin resistance could not be assessed with the present model. It 
appears that adaptations to the 2 week MS occlusion via the angiogenic process 
have reversed the impairment of the insulin-mediated microvascular recruitment 
seen in the acute model. Therefore, the implication of a reduced delivery on 
myocyte insulin resistance remains to be resolved. 
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7.1 DISCUSSION 
The main aim of the present thesis was to better understand the initial step in the 
development of type 2 diabetes. More precisely, evaluate whether the 
microvasculature of the skeletal muscle is a key player in the development of 
insulin resistance. As outlined in chapter 1, a plethora of different hypotheses is 
present in the literature that suggests mechanisms for the development of insulin 
resistance. However, the inability to discover only one unifying mechanism for 
the development of insulin resistance illustrates the complexity of this disease. 
This may also indicate that the search for the initial defect in insulin resistance 
may have been too restrictive and not considered a broad enough perspective. 
Cellular and molecular defects per se may not be as important as their 
physiopathologic effect on the vasculature. Indeed, vascular defects could be the 
link between these different mechanisms resulting in the same outcome: insulin 
resistance. 
Study of the microvascular recruitment was done for the first time in a pre-
diabetic model of insulin resistance, the 4 week HFD fed rats. The data present 
in Chapter 3 has shown that the insulin-mediated microvascular response is 
impaired in this model, and this is associated with a reduction in sensitivity to 
the insulin-mediated metabolic actions. This suggests that a defect in the 
vascular action of insulin is an early event in the aetiology of type 2 diabetes, 
supporting the hypothesis that implicates the microvasculature as an initial 
defect. This microvascular defect can cause impairment of nutrient and insulin 
delivery to myocytes and thus, may contribute to the myocyte insulin resistance. 
Muscle contraction is another process that will induce an increase in 
microvascular recruitment. Therefore, contraction-mediated microvascular 
recruitment was assessed in the 4 week HFD fed rats. This assessment was done 
using two different techniques: 1-MX metabolism and CEU. The main finding 
from Chapter 4 is that contraction-mediated metabolic and FBF response are 
preserved in a pre-diabetic state of insulin resistance. As contraction-mediated 
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glucose disposal is preserved in this model, even though the insulin-mediated 
response is impaired, it supports the hypothesis of different mechanisms for 
insulin and contraction effects. Another finding of this study was that 1-MX and 
CEU assessment of the microvascular recruitment yielded discrepant data. 1-MX 
assessment of the capillary surface area was not affected by the dietary 
intervention, while CEU assessment of the microvascular volume showed 
impairment in the HFD fed animals. This result was unexpected since 1-MX and 
CEU have previously yielded similar results in insulin-sensitive animals 
(Dawson 2002, Clark 2008). However, since HFD feeding did not affect 
contraction-mediated glucose uptake, this would indicate that capillary surface 
area is more important for the disposal of glucose than the microvascular 
volume. Therefore, caution should be taken in interpreting the results of CEU 
measures of the microvasculature. In some instances, as shown in Chapter 4, a 
decrease in MBV may not indicate a decrease in nutrients delivery. Future 
studies are needed to compare 1-MX and CEU in other models of insulin 
resistance. 
Whether the loss of insulin-mediated microvascular recruitment can impact on 
myocytes insulin responsiveness was addressed in the studies described in 
Chapter 5. Contribution of the muscle microvasculature to the insulin-mediated 
glucose uptake has been assessed previously using different acute 
pharmaceutical treatments (Rattigan 1999, Youd 2000, Clerk 2002, Wallis 
2005). However, interventions were not directly targeted to the muscle 
microvasculature and contributions from other tissues could not be excluded. 
Therefore, a novel model for the direct assessment of the microvasculature was 
developed. Reduced microvascular recruitment was created by blocking the 
terminal arterioles with 15 µm MS. This successfully prevented the insulin-
mediated increases in microvascular recruitment, leading to a 46 % decrease in 
muscle insulin-mediated glucose uptake, creating a vascular-derived state of 
insulin resistance. This finding confirmed that increased microvascular 
recruitment is required for insulin to produce the normal metabolic effects in 
skeletal muscle. 
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The effects of a chronic (2 weeks) decrease in microvascular recruitment on 
muscle insulin sensitivity were investigated in Chapter 6. However, after 2 
weeks of occlusion the angiogenic process had reversed the impairment of the 
insulin-mediated microvascular recruitment seen in the acute model. This 
finding prevented the assessment of impaired microvascular recruitment on 
myocyte insulin sensitivity. This problem of the chronic MS model may be 
overcome in two ways. The first approach could be to prevent the angiogenesis 
process by using anti-angiogenic drugs (Crawford 2009). These anti-angiogenic 
agents limit the growth of tumours by preventing the formation of new vessels 
needed by the tumour cells to maintain their high metabolic needs (Ellis 2008). 
The second approach could be to target more directly the nutritive route of the 
muscle microvasculature. This could be achieved by stimulating an increase in 
microvascular recruitment with insulin or contraction prior to MS injection. This 
would have the benefit of blocking the insulin-recruited vessels. Secondly, 
muscle contraction using electrical stimulation could be used to recruit vessels of 
the nutritive route (Clark 2000). Thus, a more targeted occlusion of the nutritive 
route may require less MS, and as such, decrease the ischemic response seen in 
Chapter 5. This may dampen the angiogenic process and allow assessment of the 
function of the microvasculature in the development of myocyte insulin 
resistance. While the chronic occlusion did not help reveal the importance of 
long-term impairment of insulin-mediated microvascular recruitment on the 
skeletal muscle insulin sensitivity, it is a good example of the high adaptability 
of this tissue. This should come as no surprise, given the physiological 
importance of the normal function of muscles for survival. 
One limitation of the present thesis is that all the experiments were done in 
anesthetised animals, which has been shown to influence total blood flow in a 
dose-dependent and tissue-specific manner (Seyde 1985, James 1986). However, 
modification of total blood flow seen in anesthetised animals may not correlate 
with modification of the microvascular recruitment. As previously shown, 
change in total blood flow does not always correlate with change in 
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microvascular recruitment (Rattigan 1997). Moreover, little is known about the 
effect of anaesthesia on the microvascular recruitment. This is partly due to the 
requirement of a motionless animal for the assessment of microvascular 
recruitment, as an increases in movement (i.e. walking in the cage) would lead to 
a modification of the flow pattern. However, it is encouraging that 
measurements done in anesthetised animals are mirrored by those done in awake 
humans. Indeed, assessment of the microvascular recruitment in the awake 
human in response to exercise (Womack 2009) and insulin (Vincent 2006) are 
similar to the anesthetised rat (Dawson 2002). Furthermore, impairment in 
insulin-mediated microvascular recruitment seen in models of insulin-resistance 
are true for both the awake state (Clerk 2006) and anaesthetised animals (Clerk 
2007). Nevertheless, until a technique measuring the microvascular recruitment 
in awake animals is developed, the effects of anaesthesia per se will remain 
unknown. 
7.2 CONCLUSION 
Collectively, studies in the present thesis confirm the pivotal role of the 
microvasculature plays in the development of skeletal muscle insulin resistance. "' 
Indeed, insulin-mediated microvascular recruitment is impaired at an early stage 
in the development of insulin resistance, while the contraction-mediated effects 
on capillary surface area are preserved. Furthermore, muscle insulin resistance 
can be artificially produced by blockage the microvasculature. Blockage of 
microvascular recruitment lead to a 46 % decrease in insulin-mediated glucose 
uptake, further confirming defects in microvascular recruitment as a likely 
candidate for the development of insulin resistance. These findings furthers our 
understanding of the aetiology of type 2 diabetes, beginning with loss of insulin-
mediated microvascular recruitment, and emphasises the microvasculature as an 
interesting therapeutic target for the management of type 2 diabetes. 
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These findings convincingly position an impairment of microvascular 
recruitment in the early stage of insulin resistance. Thus, a proposed mechanism 
can be constructed from these and other published findings. 
The western society lifestyle is characterised by increased calorie intake (with 
the majority in the form of fats) and decreased energy expenditure (less 
exercise). This imbalance translates as an increase in exposure to fatty acids, 
which can lead to many adverse effects: increase in adipose tissue mass, 
adipocytes of increased size as well as increased muscle and liver storage of 
fatty acid (Reaven 1988, Hamdy 2005, Goossens 2008). A further consequence 
is an accumulation of the fatty acid in adipocytes localised around arterioles of 
the microvasculature (Bakker 2009). These perivascular adipocytes of increased 
sized have been shown to secrete TNF-a (Chatterjee 2009). According to the 
vasocrine hypothesis (Yudkin 2005), paracrine secretion of inflammatory 
adipokines (e. g. TNF-a) by perivascular adipocytes of increase sized, as well as 
higher circulating level of FF A, could impair the endothelium dependent 
vasodilation in response to insulin. At the level of terminal arterioles, this will 
translate as an impainnent of the insulin-mediated microvascular recruitment. 
Circulating levels of glucose and insulin will therefore have limited access to the 
myocyte of the nutritive route, resulting in decreased insulin-mediated glucose 
uptake. In the long-term, prolonged impairment of insulin-mediated 
microvascular recruitment may lead to changes in the intracellular function of 
the insulin signalling pathway, corresponding to the defects associated with latc-
stage type 2 diabetes (Defronzo 1985, Zierath 1998, Ryder 2001, Karlsson 
2007). 
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